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ABSTRACT 
Acetyl-CoA carboxylase is the first and committed step of de novo fatty acid synthesis in 
all organisms.  In Escherichia coli, the enzyme is expressed as separate proteins for the three 
functional components: a biotin carboxylase, a biotin carboxyl carrier protein, and a 
carboxyltransferase.  The carboxyltransferase enzyme has an α2β2 heterotetrameric quaternary 
arrangement.  The crystal structure of the β subunit revealed a zinc-binding domain, a feature 
common among nucleic acid-binding proteins.  Carboxyltransferase preferentially binds mRNA 
coding for its two subunits over other nucleic acids, suggesting a means by which the enzyme 
can regulate its own expression.  In the first study, the role played by the zinc-binding motif in 
carboxyltransferase is revealed through site-directed mutagenesis of the four coordinating 
cysteinyl residues.  Results indicate that the zinc-binding domain is involved in both enzymatic 
activity of the enzyme as well as mediating binding of the enzyme to its own subunit mRNA.  In 
this utility, the zinc-binding domain as a structural feature physically links the two functional 
aspects of the enzyme, possibly as a means to evolutionally conserve the capacity to regulate its 
own translation.  In the second study, the individual interactions of carboxyltransferase with 
substrate and carboxyltransferase with mRNA are representated by mathematical modeling in an 
effort to validate these interactions function as a single system in regulating the activity and 
expression of carboxyltransferase in response to the metabolic state of the cell.  Comparison of 
experimental and simulation results validate the model while also suggesting a more complex 
mechanism of carboxyltransferase translational regulation not captured by the current model.
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CHAPTER 1 
INTRODUCTION 
Biotin 
Discovery and Etymology 
The vitamin biotin, as well as the entire concept of vitamins in general, was first 
described in 1901 under the name of bios (Wildiers, 1901).  In 1936 Kögl and Tönnis extracted a 
crystalline compound from dried egg yolk that was necessary for growth of yeast and proposed 
the name biotin (Kögl & Tönnis, 1936).  The name biotin is taken from the Greek biotos, 
meaning “life” or “sustenance” (Merriam-Webster, 2010).  Biotin is also known as the water 
soluble Vitamin B7 and Vitamin H from the German “Haut” (skin) (Sharman, 1982).  The 
association with skin stems from biotin deficiency leading to alopecia, conjunctivitis, and 
dermatitis.  Biotin was required for the incorporation of 14CO2 into aspartate by the yeast 
Lactobacillus arabinosum, suggesting its involvement in carbon dioxide metabolism (Lardy et 
al, 1949).  The requirement of biotin specifically for carboxylation reactions was shown through 
the incorporation of 13CO2 into oxaloacetate in cell-free extracts of Micrococcus lysodeikticus 
(Wessman & Werkman, 1950).  The first direct evidence for biotin as a required component of 
an enzyme was shown through inhibition of acetyl-CoA carboxylase by the biotin-binding 
protein avidin (Wakil et al, 1958). 
Structure 
Biotin is a bicyclic molecule, composed of an ureido (tetrahydroimidizalone) ring fused 
cis to a thiophane (tetrahydrothiophene) ring with a valeric acid moiety attached to one of the 
carbon atoms of the thiophane ring, also in the cis orientation (Figure 1.1).  This structure was 
determined through chemical degradation reactions of purified biotin (du Vigneaud et al, 1942; 
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Melville et al, 1942).  Biotin has three contiguous chiral centers in the thiophane ring making 
possible eight stereoisomers (Figure 1.1).  Successful chemical synthesis of biotin using L-(+)-
cysteine or fumaric acid as starting materials confirmed the chemical structure of the molecule 
(Harris et al, 1943; Harris et al, 1944; Goldberg & Sternbach, 1949; Confalone et al, 1975; 
Baggiolini et al, 1982). 
 
     Figure 1.1  Structure of biotin stereoisomers.  Asterisks indicate the three chiral centers. 
Biosynthesis 
In contrast to the results of early chemical syntheses containing a mixture of 
stereoisomers (Harris et al, 1943; Harris et al, 1944), the biotin prosthetic group synthesized by 
plants, fungi, and most bacteria has stringent stereospecificity ((+)-biotin in Figure 1.1) (Stokes 
& Gunness, 1944; Melville et al, 1953).  Biotin is synthesized from the amino acid alanine and 
the fatty acid pimeloyl-CoA through four enzymatic steps in all microbes investigated to date 
(Marquet et al, 2001) (Figure 1.2).  In the first committed step, the enzyme 7-keto-8-
3 
 
aminopelargonic acid (KAPA) synthase (EC 2.3.1.47), encoded by the Escherichia coli gene 
bioF, catalyzes the decarboxylative condensation of L-alanine with pimeloyl-CoA to generate 
KAPA (Ploux & Marquet, 1996; Alexeev et al, 1998).  Next, 7,8-diaminopelargonic acid 
(DAPA) aminotransferase (EC 2.6.1.62), encoded by bioA, catalyzes the addition of an amine, 
utilizing S-adenosylmethionine in the unusual role of amino donor (Stoner & Eisenberg, 1975a; 
Stoner & Eisenberg, 1975b; Eliot et al, 2002).  The last two enzymes, desthiobioin synthase 
(bioD, EC 6.3.3.3) and biotin synthase (bioB, EC 2.8.1.6), successively close the ureido and 
thiophane rings, respectively (Krell & Eisenberg, 1970; Tse et al, 2006). 
Nature’s Selection of Biotin as Carboxyl Carrier 
The biosynthesis of biotin requires many cellular resources including translation of the 
biosynthetic enzymes, the amino and fatty acid starting materials, and other substrates such as S-
adenosylmethionine, ATP, and CO2.  This investment by the cell creates a cofactor used by 
enzymes to accomplish otherwise difficult chemistry.  The use of metal ions and cofactors in 
enzymes augments and broadens the 20 amino acids’ ability to perform chemical reactions.  For 
example, metal ions can be used to activate water molecules that amino acid residues alone 
otherwise could not, as in the use of enzyme-bound Zn+2 assisting nucleophilic attack by water 
on carbon dioxide in carbonic anhydrase (Lindskog, 1997).  Cofactors are often employed to 
carry small molecules, as in the case of S-adenosylmethionine serving as the preferred methyl 
donor over the unreactive methionine.  Nature’s preference for biotin as the cofactor in the 
chemistry of carboxylation owes to the ease at which a carboxyl group may attach to the 1΄ 
nitrogen of the ureido ring (Figure 1.1) (Guchhait et al, 1974b).  This is due to tautomerism of 
biotin (Figure 1.3) from the keto form to an enolate-like structure upon deprotonation at the 1΄ 
nitrogen, greatly increasing that atom’s nucleophilicity.  The relative stability of carboxybiotin 
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Figure 1.2  Biosynthesis of biotin from pimeloyl-CoA and alanine. 
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with a half-life of 151±18 min at pH 7 (Tipton & Cleland, 1988) results in part from a fully 
conjugated carboxyurea moiety evidenced by its planarity (Stallings et al, 1980).  The steric 
crowding by the presence of the cis-thiophane ring was shown by Tipton and Cleland (1988b) to 
be responsible for a 30 fold increase in resistance to decarboxylation at low pH compared to the 
monocyclic analogue (N-carboxyimidazolidone).  They suggested that the thiophane ring imparts 
stability to carboxybiotin through hinderance of the 1´ nitrogen from achieving the tetrahedral 
geometry required for spontaneous decarboxylation (Tipton & Cleland, 1988b).  The stable 
carboxybiotin more readily decarboxylates upon binding to the active site of a biotin-dependent 
enzyme (Moss & Lane, 1971), where alteration of the geometry of the 1´ nitrogen to favor 
tetrahedral arrangement results from rotation of the carboxyl group out of the plane of the ureido 
ring, making the bound carboxyl group more labile.  Nature chose biotin as the preferred carrier 
of carbon dioxide due to its ability to alternate between a relatively stable carboxybiotin and a 
carboxybiotin that readily decarboxylates.  Binding to the active site of a biotin-dependent 
enzyme serves as a mechanical switch between these two states. 
 
 
 
Figure 1.3  Tautomerism of biotin. 
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Biotin-Dependent Enzymes 
Classes 
Biotin-requiring enzymes catalyze reactions in biochemistry involved in fatty acid 
synthesis, gluconeogenesis, amino acid catabolism, ion transport across membranes, and 
utilization of urea as the sole source of nitrogen for growth.  Classification of each enzyme into 
one of three types, Class I, II, or III, depends on whether it catalyzes the anabolic incorporation 
of CO2, the release of CO2 in a catabolic pathway, or the transfer of a carboxyl group from donor 
to acceptor molecule, respectively (Samols et al, 1988).  Class I biotin-dependent enzymes, 
termed carboxylases, use bicarbonate as the carboxylate source and hydrolyze ATP to 
carboxylate biotin using a biotin carboxylase (BC) activity.  These enzymes then transfer the 
carboxyl group from carboxybiotin to an acceptor molecule designated by the enzyme name 
using a carboxyltransferase (CT) activity (Moss & Lane, 1971).  The six Class I biotin-dependent 
carboxylases are pyruvate carboxylase (EC 6.4.1.1), acetyl-CoA carboxylase (EC 6.4.1.2), 
propionyl-CoA carboxylase (EC 6.4.1.3), 3-methylcrotonyl-CoA carboxylase (EC 6.4.1.4), 
geranyl-CoA carboxylase (EC 6.4.1.5), and urea carboxylase (EC 6.3.4.6).  All three members of 
Class II biotin-dependent decarboxylases, oxaloacetate decarboxylase (EC 4.1.1.3), 
methylmalonyl-CoA decarboxylase (EC 4.1.1.41), and glutaconyl-CoA decarboxylase (EC 
4.1.1.70), are carbon-carbon lyases that release CO2 following its transfer to biotin in the 
decarboxylation of the organic molecules in their namesakes.  Class III has one member, 
methylmalonyl-CoA carboxytransferase (transcarboxylase, EC 2.1.3.1) which catalyzes the 
carboxylation of pyruvate to oxaloacetate with methylmalonyl-CoA acting as the carboxyl donor 
(Wood & Kumar, 1985).  Unlike members of the first two classes, this enzyme neither consumes 
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nor releases CO2, and is simply a transfer of the carboxyl group from methylmalonyl-CoA to 
biotin, and then to pyruvate. 
Covalent Attachment of Biotin 
Biotin is covalently attached to all biotin-dependent enzymes by a biotin protein ligase 
(EC 6.3.4.15) (Figure 1.4) at an ε-amino group of a specific lysyl residue in the consensus 
tetrapeptide sequence Ala-Met-Lys-Met (Peck et al, 1952; Samols et al, 1988).  The attachment 
of biotin to the target lysyl residue is a two-step reaction (Figure 1.4) closely analogous to that 
performed by amino acyl-tRNA synthetases: activation of biotin by attachment of AMP through 
hydrolysis of ATP, followed by exchange of this bound AMP for the ε-amino group of the target 
lysyl residue (McAllister & Coon, 1966).  This mechanism for attachment of biotin to biotin-
dependent enzymes is conserved throughout biology, with biotin protein ligases from different 
species able to biotinylate carboxylases from numerous organisms (Cronan & Wallace, 1995; 
Leon-Del-Rio et al, 1995; Tissot et al, 1996).  In E. coli, the enzyme birA attaches biotin to a 
single protein, the biotin carboxyl carrier protein (BCCP) of acetyl-CoA carboxylase (Lane et al, 
1964). 
Two Distinct Reaction Sites 
Biotin-dependent enzymes proceed by a ping-pong mechanism, based on the 
nomenclature of Cleland (1963).  The classical ping-pong mechanism is illustrated in Scheme 
1.1, where A and B represent substrates and P and Q represent products.  One feature of this 
mechanism is the required release of the first product (P) prior to addition of the second substrate 
(B), a consequence of these two molecules sharing the same binding site on the enzyme, giving 
this mechanism the alternative name “one site” ping-pong.  For a “one site” ping-pong reaction, 
it is assumed that A and Q bind at a common site on one enzyme form, E, and that P and B also 
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Figure 1.4  Attachment of biotin cofactor to biotin-dependent enzymes.  Shown is the biotin 
carboxyl carrier protein (BCCP) from E. coli indicating the lysine to which biotin is covalently 
attached by biotin ligase. 
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bind at this same site, but on a different enzyme form, E*, the modified enzyme after transfer of 
a piece from A.  Competition for the single binding site leads to different types of product 
inhibition among the binding molecules.  The type of inhibition exhibited by product Q versus 
substrate A and product P versus substrate B at saturating concentrations of the nonvaried 
substrate will be competitive, since binding of one prevents binding of the other on the same 
enzyme form.  On the contrary, the type of inhibition exhibited by P versus A and Q versus B 
will be noncompetitive since these pairs bind to different forms of the enzyme (Cook & Cleland, 
2007). 
Deviation from expected results for a classical ping-pong mechanism was the first 
indication that biotin-dependent enzymes did not fit this mechanism exactly.  Analysis of product 
inhibition patterns for the Class III enzyme transcarboxylase showed patterns opposite that 
described above for a “one site” ping-pong mechanism, with P competitive versus A and 
noncompetitive versus B (Northrop, 1969).   A logical explanation reconciling this inconsistency 
is that A and P bind to one site and B and Q bind to a second site, resulting in the “two site” 
mechanism shown in Scheme 1.2 (Northrop, 1969).  In this scheme, the first substrate (A, the 
carboxyl donor) binds, transfers a carboxyl group to the enzyme-bound biotin while in the 
process becoming decarboxylated (P), and converts the enzyme from form (E) to (E*), where 
(E*) represents the carboxylated enzyme.  The now-decarboxylated substrate dissociates from 
the enzyme as the first product (P).  The second substrate (B, the carboxyl acceptor) binds, 
reclaims the carboxyl group derived from (A), and subsequently leaves as the second product 
(Q), returning the enzyme to its original form (E).  Further evidence that the two half reactions of 
biotin-dependent enzymes occur at separate sites is given by studies using product inhibition in 
pyruvate carboxylase from eukaryotes (Barden et al, 1972; McClure et al, 1971a; McClure et al, 
10 
 
1971b; Ashman & Keech, 1975).  Pyruvate carboxylase catalyzes the ATP (A1)-dependent 
carboxylation of pyruvate (B) to oxaloacetate (Q) using bicarbonate1 as the carboxyl source.  P in 
Scheme 1.2 for pyruvate carboxylase represents ADP + Pi.  Product inhibition by ADP was 
competitive versus ATP and uncompetitive versus pyruvate.  Just as with transcarboxylase, the 
inhibition patterns show that molecules combining in a single site (i.e., A and P) are mutually 
competitive, while molecules which combine at different sites, but react with the same form of 
the enzyme, are either noncompetitive or uncompetitive versus one another (i.e., B and P).  The 
most compelling evidence to unequivocally establish distinct sites for each half reaction was 
shown in E. coli acetyl-CoA carboxylase, where these sites are on separate polypeptides, BC and 
CT (Alberts & Vagelos, 1968; Alberts et al, 1969; Dimroth et al, 1970; Guchhait et al, 1971; 
Alberts et al, 1971; Fall & Vagelos, 1972; Polakis et al, 1974; Guchhait et al, 1974a). 
Acetyl-CoA Carboxylase Structure 
Acetyl-CoA carboxylase catalyzes the biotin-dependent carboxylation of acetyl-CoA to 
form malonyl-CoA, which takes place in two separate half reactions (Scheme 1.3).  The first half 
reaction is catalyzed by biotin carboxylase (BC), where ATP is used to activate bicarbonate for 
carboxylation of biotin.  The natural substrate is the biotinylated BCCP.  The second half 
reaction, catalyzed by carboxyltransferase (CT), transfers the activated carboxyl group from 
carboxybiotin to acetyl-CoA to form malonyl-CoA, regenerating biotin for another round of 
catalysis. 
Subunit and Gene Organization 
The BC, BCCP, and CT functional units of acetyl-CoA carboxylase correspond to three 
domains or subunits of the enzyme.  Chloroplasts and both Gram-positive and Gram-negative 
                                                 
1 In the transcarboxylase reaction methylmalonyl-CoA serves as the carboxy donor, whereas in all biotin-dependent 
carboxylases, including pyruvate carboxylase, ATP-activated bicarbonate serves as the carboxy donor.  In Scheme 
1.2, ATP and bicarbonate are both represented by A, in which the order of addition to the enzyme is not specified. 
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Scheme 1.1  Classical or “one site” ping-pong enzyme reaction mechanism. 
 
 
 
Scheme 1.2  “Two site” ping-pong enzyme reaction mechanism. 
 
 
Scheme 1.3  The two half reactions of acetyl-CoA carboxylase. 
 
12 
 
bacteria express the individual components as separate polypeptides.  For example, acetyl-CoA 
carboxylase from E. coli is a homodimeric BC of 50kDa subunits, a homodimeric BCCP of 
17kDa subunits, and an α2β2 heterotetrameric CT of 35 and 31 kDa subunits, respectively 
(Guchhait et al, 1974a; Kannangara & Stumpf, 1972; Cronan & Waldrop, 2002).  In contrast, the 
eukaryotic version of acetyl-CoA carboxylase is expressed as one long polypeptide chain with 
multiple domains for the three functional units.  Examples include acetyl-CoA carboxylase 
isolated from rat liver, parsley, and wheat, with large molecular weights of 230, 210, and 240 
kilodaltons (kDa), respectively (Tanabe et al, 1975; Egin-Bühler et al, 1980).  In animals, 
including humans, there are two isoforms of acetyl-CoA carboxylase, a 265 kDa form found in 
the cytosol (ACC1) and a larger 280 kDa form in mitochondria (ACC2) (Thampy, 1989).  An 
additional 136 residues account for the additional mass of ACC2 compared to ACC1, 114 of 
which comprise a unique N-terminal sequence targeting the protein to mitochondrial membranes 
(Abu-Elheiga et al, 2000). 
The occurrence of domains within the eukaryotic enzyme with the same functions as the 
individual proteins in some bacterial acetyl-CoA carboxylases suggests the evolution of the 
eukaryotic enzyme is a consequence of gene fusion resulting in a single polypeptide.  Amino 
acid sequence alignments of acetyl-CoA carboxylases from animals, plants, fungi, and bacteria 
show high sequence homology between neighboring regions of the eukaryotic enzymes and 
individual proteins from some bacteria, suggesting similar functions (Toh et al, 1993).  Some 
organisms show fusion of only two of the four acetyl-CoA carboxylase genes.  For example, the 
BC and BCCP functions are fused into a single protein in acetyl-CoA carboxylase from 
Mycobacteria sp. (Haase et al, 1982; Norman et al, 1994).  Acetyl-CoA carboxylase subunit 
composition in the archaea Acidianus brierleyi retains separate BC and BCCP genes, however 
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the carboxyltransferase function resides within a single polypeptide (Chuakrut et al, 2003).  This 
is also the case for the analogous CT domains of Streptomyces coelicolor and Saccharomyces 
cerevisiae (Diacovich et al, 2004; Zhang et al, 2003).  Figure 1.5 demonstrates the four different 
variations on subunit organization of acetyl-CoA carboxylases exemplified by E. coli (EC) with 
individual polypeptides for each function, Mycobacterium smegmatis (MS) with a fused 
BCCP/BC peptide but separate subunits for CT, S. coelicolor (SC) with a fused CT peptide but 
separate proteins for BCCP and BC, and Homo sapiens (HS) with a single multidomain protein 
containing all functional domains.  Unlike the multi-domain polypeptides found in eukaryotes, 
the separation of functions into distinct proteins in E. coli acetyl-CoA carboxylase facilitated the 
structural and functional studies of individual components of the enzyme. 
 
Figure 1.5  Subunit organization of acyl-CoA carboxylases from E. coli (EC), Mycobacterium 
smegmatis (MS), S. coelicolor (SC), and Homo sapiens (HS). 
 
Biotin Carboxylase Three-Dimensional Structure 
Examination of the structure of BC began in 1994 with a 2.4 Å resolution crystal 
structure (Figure 1.6) (Waldrop et al, 1994).  The individual subunits of E. coli BC can be 
described by a set of three domains.  The first 103 residues constitute an N-terminal domain, 
reminiscent of a Rossman fold, or dinucleotide binding motif.  Two connecting helices lead to 
the region defined by residues 131-203, termed the “B domain.”  Consisting of two alpha-helices 
atop three strands of β-sheet, this domain protrudes from the main body of the protein.  The 
remainder of the 449 residue protein forms the C-terminal domain and constitutes the bulk of the 
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body of the enzyme.  Dominated by an eight-stranded antiparallel β-sheet and containing a 
smaller three-stranded β-sheet, the C-terminal domain forms a basket that holds the N-terminal 
domain.  Together, these two regions form a cup-shaped structure in the body of BC.  The 
structure of the BC domain of mitochondrial human acetyl-CoA carboxylase (ACC2) has been 
solved in the phosphorylated and dephosphorylated forms, revealing the phosphorylated serine is 
disruptive to dimer polymerization (Cho et al, 2008; Cho et al, 2010).  Upon binding of the ATP 
substrate, the B domain rotates 45° relative to the N- and C-terminal domains, acting as a “lid” 
over the active site (Thoden et al, 2000a; Chou et al, 2009).  This large conformational change in 
the closing motion of the B-domain is permitted by a hinge that lies in the two stretches of loops 
that lead to and from the B-domain (Waldrop et al, 1994; Thoden et al, 1999a; Lill et al, 2008; 
Novak et al, 2009).  Computational modeling of BC crystal structures with and without bound 
ATP demonstrates the closure of the B-domain may also be associated with conformation 
changes at the dimer interface, suggestive of subunit interaction or communication (Novak et al, 
2009).  In total, the 36 structures of BC from numerous organisms deposited in the protein data 
bank (www.pdb.org) as of the writing of this dissertation have been helpful in assigning 
locations to binding sites for substrates and in providing a structural basis for enzyme activity. 
Crystal structures also reveal extensive structural similarity between BC and the ADP-
forming peptide synthetases glutathione synthetase and D-Ala:D-Ala ligase (Artymiuk et al, 
1996).  Despite catalyzing reactions in different metabolic pathways, these enzymes have in 
common a coupling of ATP hydrolysis to carbon-nitrogen bond formation (Artymiuk et al, 
1996).  Each of these enzymes possesses an ATP-binding pocket of antiparallel β-sheets, and the 
respective reactions proceed through acyl-phosphate intermediates (Artymiuk	  et	  al,	  1996;	  Matsuda	  et	  al,	  1996;	  Galperin	  &	  Koonin,	  1997).  Having similar mechanisms resulted in an 
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evolutionarily conserved three-dimensional structure able to accomplish the comparable 
chemistry.  The crystal structure of carbamoyl phosphate synthetase (Thoden et al, 1997) also 
shows a similar structure to BC, glutathione synthase, and D-Ala:D-Ala ligase.  Additionally, in 
a manner similar to BC, the B-domain of carbamoyl phosphate synthetase was also shown to 
close upon ATP binding (Thoden et al, 1999a).  Glutathione synthase orders a flexible loop over 
the active site upon ATP binding (Tanaka et al, 1992; Tanaka et al, 1993, Kato et al, 1994).  A 
comparable conformational change has yet to be shown for D-Ala:D-Ala ligase.  The structural 
and mechanistic similarities among this group led to the establishment of an ATP-grasp family of 
enzymes with BC, glutathione synthase, D-Ala:D-Ala ligase, and carbamoyl phosphate 
synthetase as founding members.  Subsequent sequence alignment searches and crystal structures 
have added new members including but not limited to: pyruvate carboxylase, propionyl-CoA 
carboxylase, ribosomal protein S6 modification protein, urea amidolyase, tubulin-tyrosine ligase, 
succinyl-CoA synthetase, malate-CoA ligase, ATP-citrate lyase, and three enzymes of purine 
biosynthesis (Wang et al, 1998; Galperin & Koonin, 1997; Thoden et al, 1999b; Thoden et al, 
2000b). 
Carboxyltransferase Three-Dimensional Structure 
The crystal structure of the CT component of acetyl-CoA carboxylase from E. coli and 
Staphylococcus aureus was solved at resolutions of 3.0 Å and 2.0 Å, respectively (Bilder et al, 
2006), revealing the α2β2 heterotetrameric quaternary arrangement first suggested by gel-
filtration and sedimentation equilibrium analysis experiments (Guchhait et al, 1974a).  The 
tetrameric arrangement of subunits is a truncated rectangular pyramid, with α and β monomers 
occupying roughly equivalent volumes at opposite corners (Figure 1.7).  The tetramer can be 
described as a dimer of dimers, with each α/β pair constituting one of two complete active sites.  
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Closer inspection of individual monomers reveals that each wedge-shaped polypeptide harbors 
an α/β spiral core consisting of a seven-stranded mixed beta-sheet surrounded by alpha-helices 
which taper toward the apex of the tetrameric pyramid.  The base of the pyramid is generated by 
the 60° tilt between pairs of α and β monomers creating an alignment of beta-strands, structuring 
the catalytic platform in each dimer.  Where the symmetry of the two monomers is broken lies in 
the protrusions from the base of the pyramid.  The N-termini of the subunits are drastically 
different with two helices on the α subunit and a βαβ motif on the β subunit.  Also dissimilar are 
structures forming the walls and a partial canopy over the active site cleft comprised of three 
helices from the α subunit and one from the β subunit.  The gaps between these structures 
provide differing access to the catalytic platform for the two substrates.  The most surprising 
discovery in the structure of bacterial CT is the presence of a zinc-binding domain at the N-
terminus of the β subunit in the βαβ motif.  Homologous structures are not present in the 
eukaryotic acetyl-CoA carboxylase, making its occurrence on the prokaryotic enzyme somewhat 
of an enigma. 
Acetyl-CoA Carboxylase as an Antibacterial Drug Target 
The persistent increase in drug-resistant pathogenic bacteria has created a continual 
demand for new antibiotics, necessitating the discovery of new targets.  Since fatty acids in 
bacteria are required solely for membrane production, the enzymes of fatty acid synthesis are 
targets for antibacterial development.  For example, isoniazid (Banerjee et al, 1994; Dessen et al, 
1995; Rozwarski et al, 1998) and triclosan (McCurry et al, 1998; Heath et al, 1998; Levy et al, 
1999) inhibit enoyl-ACP reductase.  Since acetyl-CoA carboxylase is also an enzyme in the fatty 
acid synthesis pathway, it could also be a target for antibiotic development. 
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The individual components of acetyl-CoA carboxylase were identified as essential for 
fatty acid production.  E. coli containing temperature sensitive mutants in the genes encoding BC 
(Campbell & Cronan, 2001), BCCP (Li & Cronan, 1992a), and the β subunit of CT (Li et al, 
1992) show a lack of fatty acid synthesis at nonpermissive temperatures, designating these genes 
as indispensable in the generation of fatty acids.  Moreover, the inability to create knockout 
strains of bacteria deficient in the acetyl-CoA carboxylase genes supports the enzyme as being 
essential for growth, and thus a target for bacterial antibiotics (Pfizer, personal communication). 
Developing molecules that inhibit the BC component of acetyl-CoA carboxylase resulted 
in three new classes of antibacterial compounds.  First, a screen of Pfizer’s anti-cancer 
compound library comprising known eukaryotic tyrosine protein kinase inhibitors yielded the 
pyridopyrimidine class of antibacterial molecules (Miller et al, 2009).  The pyridopyrimidines 
were unsuccessful in inhibiting the Gram-positive species tested (S. aureus, Streptococcus 
pneumoniae, and Enterococcus faecalis), but inhibited the growth of several Gram-negative 
bacteria (E. coli, Hemophilus influenzae, and Moraxella catarrhalis).  Generating 
pyridopyrimidine-resistant mutants of these susceptible species allowed tracking of the 
resistance-conferring mutations to the BC gene (Miller et al, 2009).  Mapping the mutations 
imparting resistance onto the crystal structure of E. coli BC localized the residues to the ATP-
binding pocket, indicating interaction of the pyridopyrimidine with the active site.  Crystal 
structures of pryidopyrimidines with E. coli, H. influenzae, and Pseudomonas aeruginosa BC 
clearly show the molecule bound in place of ATP (Miller et al, 2009).  This was not surprising, 
as the pyridopyrimidines were originally identified as inhibitors of eukaryotic kinases, which 
also bind ATP.  In a second study aimed at identifying inhibitors of BC, the amino acid binding 
contacts to pyridopyrimidines seen in the crystal structure with BC served as criteria to virtually 
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screen 2.2 million compounds, 48 of which showed an ability to inhibit BC in subsequent 
biochemical assays with IC50 values less than 10 µM (Mochalkin et al, 2009).  Additionally, a 
library of 5200 small molecules was assayed for inhibition of BC, resulting in six compounds 
with IC50 values less than 95 µM (Mochalkin et al, 2009).  One of these compounds, an amino-
oxazole, was further optimized by chemical modification to promote increased contact with BC 
residues in the active site (Mochalkin et al, 2009).  Amino-oxazoles were tested against 40 
human protein kinases and mammalian acetyl-CoA carboxylase, giving IC50 values greater than 
10 µM, indicating some specificity for the bacterial BC (Mochalkin et al, 2009).  However, this 
project and further development of pyridopyrimidine antibacterial compounds were abandoned 
due to lack of efficacy against Gram-positive bacteria (Pfizer, personal communication).  A third 
class of antibacterial compounds that act by inhibiting BC was discovered by screening a library 
of synthesized molecules based on a cyclized substituted nitrobenzoic acid scaffold (Cheng et al, 
2009).  Structure-based drug design, an iterative process of chemical modification and co-
crystallization with the target protein (BC in this case) led to the benzamidazole-carboxamide 
antibacterial compounds, some with IC50 values as low as 20 nM (Cheng et al, 2009).  This class 
of molecules shows broad-spectrum antibacterial activity and did not inhibiting eukaryotic 
caroboxylases or human kinases (Cheng et al, 2009). 
The CT component of acetyl-CoA carboxylase is also the target of several antibacterial 
natural products.  Andrimid and the structurally similar moiramide-B are members of a new class 
of pseudopeptide pyrrolidine dione antibacterial compounds and potent competitive inhibitors 
(Ki approximately 5 nM) of CT with respect to malonyl-CoA2 (Freiberg et al, 2004).  These 
natural products exhibit antibiotic activity against Gram-negative (IC50 ~ 6 nM) and Gram-
                                                 
2 In the assay, activity was measured in the reverse, or non-physiological, direction using malonyl-CoA and biocytin 
as substrates, acetyl-CoA and carboxybiocytin as products.  Biocytin is a biotin molecule with a lysine appended to 
the carboxyl group of the valeric acid side chain via an amide linkage at the ε-amino group. 
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positive (IC50 < 500 nM) bacteria, but IC50 values greater than 100 µM are observed against 
eukaryotic acetyl-CoA carboxylase, indicating selective inhibition of bacterial CT (Freiberg et 
al, 2004).  Andrimid-producing bacteria encode an alternate accD gene, imparting resistance to 
the natural product antibiotic through a single M203L mutation (Liu et al, 2008).  Freiberg, et al 
(2004) were able to generate variants of E. coli CT less susceptible to pyrrolidine dione 
inhibition through a S207Y mutation in accD.  The well-known antimicrobial properites of 
another natural product, cinnamon oil, and its chief component, trans-cinnamaldehyde, act by 
competitive inhibition of E. coli CT with respect to biocytin2 (Meades et al, doi: 10.1055/s-0030-
1249778).  Further optimization of these chemical leads guided by the three-dimensional 
structures of BC and CT is required to produce effective specific inhibitors of the antibacterial 
target acetyl-CoA carboxylase. 
Acetyl-CoA Carboxylase Reaction Mechanism 
Biotin Carboxylase 
The carboxylation of biotin proceeds via the formation of a carboxyphosphate 
intermediate.  A direct interaction of ATP and bicarbonate was demonstrated in propionyl-CoA 
carboxylase and E. coli BC by an exchange of 18O from bicarbonate to phosphate (Kaziro et al, 
1962; Ogita & Knowles, 1988).  Additional evidence for the existence of a carboxyphosphate 
intermediate comes from the finding that BC will catalyze ADP phosphorylation to ATP using 
carbamyl phosphate, an analog of carboxyphosphate, as a substrate in the reverse reaction 
(Ashman & Keech, 1975; Polakis et al, 1974; Polakis et al, 1972).  Furthermore, the inclusion of 
BC in the ATP-grasp family of enzymes suggests a carboxyphosphate intermediate since other 
family members proceed by acyl-phosphate intermediates. 
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The unstable carboxyphosphate intermediate (predicted half life = 70 ms at pH 7) (Sauers 
et al, 1975) is used by BC to carboxylate the 1΄ nitrogen of biotin.  The 1´ N as well as the more 
nucleophilic ureido 2´ O (Figure 1.1) were both proposed as the site of attachment of the 
carboxyl group on biotin.  All biotin-dependent carboxylases have in common the carboxylation 
of biotin as the first half reaction, allowing investigation of a common mechanism using biotin-
dependent carboxylases other than E. coli BC.  Lynen and Knappe (Lynen et al, 1959; Lynen et 
al, 1961, Knappe et al, 1961) trapped the intermediate N1-(methoxycarbonyl)-D-biotin methyl 
ester of the biotin-dependent 3-methylcrotonyl-CoA carboxylase by using the carboxyl 
methylating agent diazomethane, implying the actual intermediate was N1-carboxybiotin.  
Guchhait et al. (1974b) confirmed the intermediate as N1-carboxybiotin and not O2-
carboxybiotin by chemically synthesizing N1-carboxybiotinol and N1-carboxybiotin, which 
function as substrates for the E. coli CT and reverse BC reactions, respectively.  Berger et al. 
(1996) synthesized 15N1- and 13C2-biotin as separate substrates for enzymatic carboxylation by a 
13C-labeled carboxyl donor.  The 15N,13C and 13C,13C spin-spin couplings detected by NMR 
during the enzymatic reaction, respectively, unequivocally show the formation of a C-N bond, 
reinforcing the conclusion that biotin is carboxylated at the 1´ nitrogen. 
The formation of carboxybiotin from biotin and carboxyphosphate can occur in one of 
two ways, either as a direct reaction between carboxyphosphate and biotin, or stepwise where 
carboxyphosphate first dissociates to phosphate and carbon dioxide followed by nucleophilic 
attack of biotin on carbon dioxide.  Carbamyl phosphate synthetase is an analogous system to BC 
since it also catalyzes production of carboxyphosphate as an intermediate in the synthesis of 
carbamyl phosphate from bicarbonate, ATP, and an ammonium ion (Meister, 1989).  In the 
absence of its ammonium ion substrate that normally accepts the activated carboxyl group, the 
21 
 
carboxyphosphate intermediate breaks down into bicarbonate and phosphate.  If the 
decomposition of carboxyphosphate into bicarbonate and phosphate is enzyme catalyzed, one 
proton is released per round of catalysis and the rate of ATP hydrolysis equals the rate of proton 
production, as depicted in Scheme 1.4A.  Alternatively, if the enzyme catalyzes the formation of 
carbon dioxide from carboxyphosphate (Scheme 1.4B), the rate of proton release lags behind 
ATP hydrolysis, indicating a slower, nonenzymatic conversion of carbon dioxide to bicarbonate. 
 
Figure 1.6  Three-dimensional structure of biotin carboxylase from E. coli (PDBID: 1BNC), 
showing the organization of the three domains.  This and all ribbon drawings hereafter were 
made using the program Pymol, a product of DeLano Scientific, LLC. 
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Figure 1.7  Three-dimensional structure of carboxyltransferase from E. coli (PDBID: 2F9Y), 
showing the α2β2 heterotetrameric quaternary arrangement of subunits.  In the lower illustration, 
only a single α/β pair is shown for clarity. 
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Gibson, et al. (1998) observed a direct relationship between ATP hydrolysis and proton 
production (change in pH) for any amount of enzyme, establishing the former mechanism 
 (Scheme 1.4A) as the case with carboxyphosphate, not carbon dioxide, as the carboxylating 
entity for carbamyl phosphate synthetase.  Supporting evidence for this mechanism was obtained 
by monitoring for the production of 13CO2 while using 13C-labeled bicarbonate substrate (Gibson 
et al, 1998).  The lack of 13CO2 detected by NMR spectroscopy supports the mechanism shown 
in Scheme 1.4A with no dissociation into phosphate and carbon dioxide.  Although evidence 
exists for this mechanism in carbamoyl phosphate synthetase, it has not yet been shown for BC.  
However, since the two enzymes catalyze similar reactions by which a carboxyl group is 
attached to a nitrogenous substrate (ammonium for carbamoyl phosphate synthetase, and biotin 
for BC), one could infer that the reaction catalyzed by BC also proceeds by transfer of a carboxyl 
group directly from carboxyphosphate to biotin, not involving the transient production of carbon 
dioxide.  Other researchers have proposed that BC proceeds by the mechanism shown in Scheme 
1.4B (Chou et al, 2009) based on structural evidence showing the substrates in the active site and 
potential catalytic residues in positions to facilitate this mechanism.  Whether the mechanism in 
Scheme 1.4A is shown to occur in BC as it does in carbamoyl phosphate synthetase or whether 
Scheme 1.4B is confirmed will rely on future experimental results. 
Carboxyltransferase 
Akin to the carboxylation of biotin by BC, transfer of the carboxyl group from 
carboxybiotin to acetyl-CoA by CT could proceed by one of two mechanisms.  The first is a 
concerted pathway where following initial deprotonation of acetyl-CoA, carboxyl group transfer 
and reprotonation of biotin occur simultaneously.  Alternatively, the reaction could proceed in a 
stepwise manner, with transient formation of carbon dioxide, followed by nucleophilic attack of 
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Scheme	  1.4	  	  Two	  possible	  mechanisms	  for	  the	  decomposition	  of	  carboxyphosphate	  in	  BC.	  	  
deprotonated acetyl-CoA on the electrophilic carbon dioxide.  Deuterium and 13C isotope effect 
studies on pyruvate carboxylase (Attwood et al, 1986b) offered no support for the concerted 
mechanism of carboxyl transfer, as the 13C isotope effect was reduced when the reaction was run 
in D2O.  For a concerted pathway, one would expect this effect to remain the same or increase 
(Attwood et al, 1986b).  This suggests carboxyl transfer occurs in a stepwise mechanism for 
pyruvate carboxylase.  Since the reactions of pyruvate carboxylase and CT are very similar, it is 
not unreasonable that CT also proceeds by a stepwise mechanism, as shown in Figure 1.8. 
The stepwise chemical mechanism for CT described in Figure 1.8 requires the formation 
of enolate or enolate-like anions by acetyl-CoA and biotin.  How does CT stabilize these charged 
intermediates?  The overall structural similarity between the α and β subunits of CT leads to 
similar chemical binding motifs for the two substrates, acetyl-CoA and carboxybiotin.  The 
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crystal structure (Bilder et al, 2006) revealed a pair of conserved glycines in each subunit at the 
catalytic site (double-headed arrow in Figure 1.7), the peptidic amides of which act to stabilize 
the developing negative charges on the oxygens of biotin ureido enolate and acetyl-CoA 
thioenolate.  These oxyanion intermediates are stabilized by hydrogen bonding from what are 
termed “oxyanion holes,” hydrogen bond donors to coordinate the negatively-charged oxygen 
atoms.  The spontaneous decarboxylation of carboxybiotin in the active site of the enzyme is 
disallowed if the acetyl-CoA acceptor molecule is not bound.  Investigation of the kinetic 
mechanism of E. coli CT showed an ordered addition of substrates to the enzyme with malonyl-
CoA3 binding before biocytin (Blanchard & Waldrop, 1988).  The inability of the carboxybiotin 
substrate to bind in the active site prior to binding of acetyl-CoA prevents futile loss of the 
activated carboxyl group as carbon dioxide.  Mechanistically, Figure 1.8 also requires a general 
base to abstract a proton from the β-carbon of acetyl-CoA.  Identification of this base begins with 
determining its pK.  Blanchard and Waldrop (1988) determined the pH rate profile of CT in the 
presence and absence of the thiol-modifying agent N-ethylmaleimide.  The fact that malonyl-
CoA afforded protection from N-ethylmaleimide inactivation and the conclusion drawn from the 
profile of maximal velocity versus pH that a single group on the enzyme with a pK in the range 
of 7.2-7.6 must be deprotonated lead them to suggest that the thiolate ion of a cysteine acts as the 
catalytic base in Figure 1.8.  This is not without precedent, as the same role for a cysteine 
thiolate ion had been proposed for BC (Tipton & Cleland, 1988a) and pyruvate carboxylase 
(Attwood et al, 1986; Werneburg & Ash, 1993).  The crystal structure of CT illustrated the 
marked absence of a cysteine near the active site, leaving the yet to be identified base as a 
mystery. 
                                                 
3 In the assay, activity was measured in the reverse, or non-physiological, direction using malonyl-CoA and biocytin 
as substrates, acetyl-CoA and carboxybiocytin as products.  Biocytin is a biotin molecule with a lysine appended to 
the carboxyl group of the valeric acid side chain via an amide linkage at the ε-amino group. 
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Figure 1.8  The stepwise mechanism of CT. 
Regulation of Acetyl-CoA Carboxylase Activity and Expression 
Residing at the first and committed step of fatty acid synthesis makes acetyl-CoA 
carboxylase an appropriate target for regulation of the fatty acid synthetic pathway.  Eukaryotes 
have a complex system of regulation for acetyl-CoA carboxylase activity involving covalent 
modification by reversible phosphorylation, and allosteric modification by citrate and palmitoyl-
CoA (Wakil et al, 1983; Beaty & Lane, 1983; Kim et al, 1989).  The quaternary structure of the 
eukaryotic enzyme is a homodimer, inactivated by phosphorylation of serine residues.  The 
kinase responsible for this modification is activated by AMP and inhibited by ATP.  In this 
manner, acetyl-CoA carboxylase (and thus fatty acid synthesis) is downregulated when the 
ATP/AMP ratio is low.  As the ATP/AMP ratio rises in the cell, dephosphorylation of acetyl-
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CoA carboxylase by protein phosphatase 2A reactivates the enzyme.  Protein phosphatase 2A is 
activated by insulin and inhibited by glucagon, allowing regulation of acetyl-CoA carboxylase 
activity in response to extracellular hormonal signals.  Complementing activity regulation by 
phosphorylation, allosteric binding of citrate promotes the formation of long filaments, 
enzymatically active, non-covalently bound polymers of acetyl-CoA carboxylase (Martin & 
Vagelos, 1962).  The end product of fatty acid synthesis, palmitoyl-CoA, has the reverse effect, 
promoting depolymerization into inactive, isolated dimers.  The level of phosphorylation dictates 
the concentration of citrate needed to promote polymerization of acetyl-CoA carboxylase 
(Thampy & Wakil, 1988). 
Unlike the posttranslational regulation of acetyl-CoA carboxylase in eukaryotes, E. coli 
regulation of the enzyme is rooted in transcriptional and translational events.  Having multiple 
proteins, the coordinated expression of enzyme components presents a problem.  Of the four 
genes expressing the individual polypeptides that comprise E. coli acetyl-CoA carboxylase 
(accA-D), only those encoding the BCCP and BC components, accB and accC, respectively, are 
organized into a transcriptional operon (Li & Cronan, 1992a; Li & Cronan, 1992b).  In vivo 
expression of BCCP and BC from the accBC operon showed a non-linear response to gene copy 
number, indicating the presence of a negative regulatory effect (Li & Cronan, 1993).  
Additionally, overexpression of BCCP from a plasmid-encoded gene in E. coli resulted in 
marked growth inhibition whereas coexpression of BCCP and BC from the same vector did not 
(Li & Cronan, 1992a).  Li and Cronan (1992a) interpret this as a downregulation of 
chromosomal BC expression by BCCP in the first overexpression experiment, with BCCP 
serving as a negative transcriptional regulator of the accBC operon.  Interestingly, 
overexpression of a 44-residue N-terminal fragment of BCCP also resulted in severe inhibition 
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of transcription from the accBC operon, implying this small region of the protein is responsible 
for that regulatory function (James & Cronan, 2004).  James & Cronan (2004) speculate that the 
transcriptional regulatory function of BCCP may be modulated through interaction with another 
protein, perhaps by binding to BC.  The BCCP/BC complex is unstable in vitro and the same 
instability may exist in vivo (James & Cronan, 2004).  If so, the amount of BCCP available for 
its regulatory function may depend on availability of substrates, such as ATP, for BC and 
thereby provide a link between metabolic state of the cell, enzyme activity, and protein 
expression, regulated at the level of transcription by BCCP. 
In stark contrast to the coordinate expression of the accBC operon, the genes encoding 
the two subunits of CT (accA and accD) are located in distant regions of the genome from one 
another as well as from accBC (Blattner et al, 1997).  Since the quaternary structure of the 
complete CT enzyme consists of two copies each of subunits α (accA) and β (accD), there must 
exist a mechanism of coordinated expression of these two proteins.  This dissertation will focus 
on E. coli acetyl-CoA carboxylase and how the two subunits of its CT component act to regulate 
activity of the enzyme and modulate expression at the translational level. 
Purpose of Dissertation 
The purpose of the research presented here is two-fold.  The first aim is to evaluate the 
role of the zinc domain on the β subunit of E. coli CT, noticeably absent in the eukaryotic 
version of the enzyme.  Recent work has shown that wildtype CT is able to bind nucleic acids 
(Benson et al, 2008).  Does the conspicuous presence of a zinc finger in the enzyme impart this 
functionality, and if so, what purpose does it serve?  The answer to this question is approached 
through site-directed mutagenesis of the zinc-coordinating cysteine ligands and observation of 
the effects on enzyme catalysis and nucleic acid binding.  The second aim is to evaluate the 
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resultant model of CT autoregulation of activity and expression.  Does the interaction of CT with 
nucleic acid exist separately from CT binding its substrate, or do the two functions constitute a 
regulatory mechanism able to sense the metabolic state of the cell?  Mathematical modeling of 
the system presents an opportunity to assess whether these associations operate as a single 
dynamic system and not simply a collection of unrelated interactions. 
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CHAPTER 2 
A TALE OF TWO FUNCTIONS: ENZYMATIC ACTIVITY AND TRANSLATIONAL 
REPRESSION BY CARBOXYLTRANSFERASE* 
 
Introduction 
Acetyl-CoA carboxylase (ACCase, EC 6.4.1.2) catalyzes the first committed step in fatty 
acid biosynthesis in all organisms.  The overall reaction is the biotin-dependent carboxylation of 
acetyl-CoA to form malonyl-CoA and it takes place in two separate half reactions (Scheme 2.1). 
 
Scheme 2.1  The two half reactions of acetyl-CoA carboxylase. 
The first half reaction is catalyzed by biotin carboxylase, where ATP is used to activate 
bicarbonate for carboxylation of biotin.  The natural substrate is the biotin carboxyl carrier 
protein (designated as Enzyme-biotin in Scheme 2.1).  The second half reaction, catalyzed by 
carboxyltransferase, transfers the activated carboxyl group from carboxybiotin to acetyl-CoA to 
form malonyl-CoA.  In eukaryotes, each of the three different proteins, biotin carboxylase, biotin 
carboxyl carrier protein and carboxyltransferase form individual domains in a single polypeptide 
chain.    In contrast, Escherichia coli encodes separate polypeptides generating a homodimeric 
biotin carboxylase (BC), biotin carboxyl carrier protein (BCCP), and an α2β2 heterotetrameric 
carboxyltransferase (CT) (Cronan & Waldrop, 2002). 
                                                 
* Nucleic Acids Research, March 1, 2010; 38(4):1217-1227. A tale of two functions: enzymatic activity and 
translational repression by carboxyltransferase.  Reproduced with permission of Nucleic Acids Research and Oxford 
University Press. 
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Because the reaction involves two separate half reactions, coordinated expression of the 
genes coding for the various subunits of bacterial ACCase is essential in order to achieve 
efficient conversion of substrate to product.  This is readily accomplished for the first half 
reaction because the genes coding for biotin carboxylase (accC) and the biotin carboxyl carrier 
protein (accB) are in a single operon that is transcriptionally controlled (Li & Cronan, 1993; 
James & Cronan, 2004).  However, the genes encoding the CT α (accA) and CT β (accD) 
subunits are not in an operon,  but are found on nearly opposite poles of the chromosome (4.5’ 
and 52.4,’ respectively) in opposing directions (Li & Cronan, 1992; Blatter et al, 1997).  Yet, the 
expression of accA and accD should yield stoichiometric amounts of the α and β subunits to 
form the α2β2 heterotetramer of CT.  Sequence analyses reveal no obvious clues to a mechanism 
of concerted expression of accA and accD, however, an alternative to transcriptional control for 
modulating expression of accA and accD has been suggested (Li & Cronan, 1993). 
The crystal structures of both E. coli (PDB: 2f9y) and Staphylococcus aureus (PDB: 2f9i) 
CT reveal a Cys4-type zinc ribbon motif on the β subunit (Bilder et al, 2006) (Figure 2.1).  The 
zinc domain forms part of a saddle-like structure with a net electropositive surface potential 
whereas the rest of the protein has a net electronegative surface potential (Bilder et al, 2006).  
Zinc finger domains are commonly associated with nucleic acid-binding proteins and previous 
studies have shown that CT does bind DNA, albeit non-specifically (Benson et al, 2008).  
Notably, DNA binding inhibited catalysis while the substrates inhibited DNA binding (Benson et 
al, 2008).  In other words, DNA binding and catalysis are reciprocally related, implying a 
physiological role for nucleic acid binding. 
In this report we show that an unusual regulatory mechanism exists by which CT 
autoregulates activity in response to metabolic needs.  Specifically, we show that the zinc 
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domain of CT is not only required for catalysis, but that it also mediates binding to the mRNA 
coding for the α and β subunits of carboxyltransferase so that CT can act as a “dimmer switch” 
to regulate translation.  These properties of the zinc domain, which is unique to bacterial CT, 
provide a mechanism for regulating enzymatic activity and for coordinating expression of the 
genes coding for the α and β subunits of carboxyltransferase. 
 
Figure 2.1  The Cys4-type Zn ribbon of E. coli carboxyltransferase with the Zn atom 
shown in grey coordinated by four cysteine residues (PDBID: 2f9y). 
 
Materials and Methods 
Reagents – Restriction enzymes and T4 DNA ligase were from New England Biolabs.  
Pfu Turbo DNA polymerase was from Stratagene.  The cloning and expression vector pETBlue-
2 and the E. coli host strains NovaBlue and BL21(DE3) were from Novagen.  Primers were 
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synthesized by MWG Biotech.  In vitro transcription kit was from Ambion.  T7 in vitro 
transcription/translation kit was from Qiagen.  [α-32P]UTP (3000Ci/mmol) and [35S]L-
Methionine (>1000Ci/mmol) were from PerkinElmer.  His-binding cartridges and all other 
reagents were from Sigma. 
Construction of Expression Vectors – The genes accA and accD coding for the α and β 
subunits of carboxyltransferase were overexpressed linked in a minioperon similar to the one 
described by Blanchard and Waldrop (1998) except that the expression vector pETBlue-2 was 
used and the his-tag was placed on the C-terminus of the β subunit.  To construct the 
minioperon, the gene encoding the α subunit of E. coli CT was amplified by PCR using pCZB2 
(Blanchard & Waldrop, 1998) as template and primers CTa5 and CTa3 (Table 2.1), digested 
with NcoI and HindIII, and cloned into equivalently digested pETBlue-2 to generate the plasmid 
pGDM8.  To make possible the use of the NcoI restriction site, an amino acid mutation, S2A, 
was introduced near the N-terminus of accA.  This mutation had no effect on the functions of the 
enzyme, either nucleic acid binding or catalytic activity.  The CTa3 primer allowed incorporation 
of the modified ribosomal binding site after the accA stop codon.  The gene for the wildtype β 
subunit of E. coli CT was amplified by PCR using pCZB1  (Blanchard & Waldrop, 1998) as 
template and primers CTb5 and CTb3, digested with HindIII and XhoI, and cloned into 
equivalently digested pGDM8 to generate the plasmid pGDM9, which was used for coexpression 
of both genes. 
Site-directed Mutagenesis – The cysteines in the zinc domain of the CT β subunit were 
mutated to alanine using the method of overlap extension (Ho et al, 1989).  Four single variants 
were generated, resulting in plasmids pGDM12-15.  Complementary oligonucleotides containing 
specific alterations in the nucleotide sequence (e.g. C30A5 and C30A3) were used to generate 
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two DNA fragments having overlapping ends.  These fragments were combined and used as the 
template in a subsequent PCR reaction using primers CTb5 and CTb3 (Table 2.1) to generate the 
full-length accD gene with the desired mutation (e.g. C30A).  Three multiple cysteine to alanine 
variants were generated by sequential site-directed mutagenesis of the C27A accD gene using 
the pairs of primers C46A5 and C46A3, C46/49A5 and C46/49A3, and C27/30A5 and 
C27/30A3.  All constructs were sequenced to confirm the mutations and verify there were no 
other changes. 
Table 2.1 
List of primers used for mutagenesis. 
Oligonucleotide Sequence (5’ to 3’) 
CTa5 CCCCATGGCTCTGAATTTCCTTGAT 
CTa3 GGCAAGCTTCTCCTTACGCGTAACCGTAGCTCAT 
CTb5 GGCAAGCTTATAATGAGCTGGATTGAACGAATT 
CTb3 GGCCTCGAGGGCCTCAGGTTCCTGATCCGG 
C27A5 GGGTGTGGACTAAGGCTGATAGCTGCGGTC 
C27A3 GACCGCAGCTATCAGCCTTAGTCCACACCC 
C30A5 CTAAGTGTGATAGCGCCGGTCAGGTTTTAT 
C30A3 ATAAAACCTGACCGGCGCTATCACACTTAG 
C46A5 GTAATCTTGAGGTCGCTCCGAAGTGTGACC 
C46A3 GGTCACACTTCGGAGCGACCTCAAGATTAC 
C49A5 AGGTCTGTCCGAAGGCTGACCATCACATGC 
C49A3 GCATGTGATGGTCAGCCTTCGGACAGACCT 
C27/30A5 CTAAGGCTGATAGCGCCGGTCAGGTTTTAT 
C27/30A3 ATAAAACCTGACCGGCGCTATCAGCCTTAG 
C46/49A5 AGGTCGCTCCGAAGGCTGACCATCACATGC 
C46/49A3 GCATGTGATGGTCAGCCTTCGGAGCGACCT 
eYFP5 GGCCTCGAGATGGTGAGCAAGGGCGAGGAGCTG 
eYFP3 GGCTTAATTAATTACTTGTACAGCTCGTCCATGCCGAG 
The boxed nucleotides are the mutations from wildtype. 
 
Expression, Purification, and Enzymatic Assay – The plasmids encoding wildtype and 
CT variants were transformed into E. coli BL21(DE3) and grown as described by Blanchard and 
Waldrop (1998) with the following exceptions.  The temperature was reduced to 25°C prior to 
induction with 2.8mM β-lactose.  Expressed protein was purified by nickel affinity 
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chromatography using a HisSelect cartridge (Sigma) following the manufacturer’s protocol.  The 
wash buffer contained 10mM imidazole, 300mM NaCl, 50mM KH2PO4, pH 7.0, and the elution 
buffer contained 200mM imidazole, 500mM NaCl, 20mM Tris-Cl, pH 8.0.  Eluents were 
subjected to 24 h dialysis first against 134mM KCl, 1mM Na2EDTA, 10mM KH2PO4, pH 7.0, 
and second against 500mM KCl, 10mM Hepes, pH 7.0, followed by concentration to 0.5-
10mg/ml using Amicon Ultra 4 (Millipore) centrifugal concentrators with a 10,000 molecular 
weight cutoff.  CT activity was measured in the reverse, or non-physiological, direction with a 
spectrophotometric assay in which the production of acetyl-CoA was coupled to citrate synthase 
and malate dehydrogenase reactions (Blanchard & Waldrop, 1998). NADH formation was 
followed spectrophotometrically at 340nm using a Uvikon 810 (Kontron Instruments) 
spectrophotometer interfaced to a computer equipped with a data acquisition program. 
Inactivation Studies – Enzyme modification by N-ethylmaleimide (NEM) was performed 
in 500mM KCl, 10mM Hepes, pH 7.0.  For NEM inactivation, reactions were initiated by the 
addition of NEM to the CT solution at a final concentration of 4mM.  An aliquot was removed 
every 5 min and assayed for enzymatic activity.  The aliquots were of sufficiently small volume 
compared with the assay volume such that the modifying agents were diluted 50-fold. 
Data Analysis – The kinetic parameters Km and Vmax were determined by nonlinear 
regression analysis.  The initial velocities versus the substrate concentration were fitted to the 
Michaelis-Menten equation using the programs of Cleland (1979).  The dissociation constant 
(Kd) for RNA binding was determined using the program Enzfitter.  The binding isotherms for 
CT binding to RNA were analyzed by fitting the data to equation 1 where Kd reflects half 
maximal saturation, Y is the fractional complex, X is concentration of CT, and Ymax is the 
maximal complex or horizontal asymptote. 
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Y = Ymax · X / (Kd + X)     (1) 
Zinc Determination and Circular Dichroism – The molar ratio of Zn to CT tetramer was 
determined using Atomic Absorption Spectroscopy using a Varian Spectra AA 220 Atomic 
Absorption Spectrometer equipped with a zinc lamp and absorption recorded at 213.9nm. Protein 
concentrations for wildtype and variants ranged from 15 to 50µM. CD spectra were recorded on 
an AVIV Model 202 CD spectropolarimeter using a 1cm pathlength quartz cuvette. Data points 
were averaged from triplicate scans from 200 to 250nm. Spectra for wildtype and each variant 
were recorded at 25°C at a protein concentration of 0.1 mg/ml in a buffer of 500mM KCl, 10mM 
Hepes, pH 7.0. 
DNA Electrophoretic Mobility Shift Assay (EMSA) – Wildtype CT and variants were 
incubated for 0.5 h at 25°C with an 800 bp linear dsDNA at final concentrations of 0.88 µM and 
50 nM, respectively.  The DNA was obtained by gel extraction following PCR using primers 
C46A5 and CTb3 and the accD gene as the template.  After addition of glycerol to a final 
concentration of 2.5%, samples were resolved on 0.8% (w/v) agarose gels in 1X TAE (40mM 
Tris-Cl at pH 8.0, 20mM acetate, 1mM Na2EDTA) followed by staining with ethidium bromide 
and visualized by UV irradiation. 
In Vitro Transcription and RNA Electrophoretic Mobility Shift Assay – A cell-free 
extract was used to produce mRNA using the MEGAscript Kit (Ambion) following the 
manufacturer’s protocol with 0.2µg PCR product as the template.  Each 20µl reaction contained 
[α-32P]UTP at 167nM.  The reactions also contained 7.5 mM ATP, CTP, GTP, and 3.75 mM 
UTP.  The resultant mRNA was purified according to the manufacturer’s instructions with the 
MEGAclear Kit (Ambion) and eluted in 100µl, to which was added 20µl of 80% glycerol and 
20µl of 10X EMSA buffer (200mM Tris-Cl at pH 8.0, 1mM Na2EDTA, 500mM NaCl, 50mM 
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MgCl2).  Seven µl of this solution was added to each 10µl reaction, with CT titrated from 0 to 
1µM in the remaining 3µl.  For the inhibition of RNA binding, acetyl-CoA was titrated from 0 to 
4.0mM.  Reactions were incubated on ice for 0.5 h. Samples were loaded with the power on onto 
prerun 5.0% (w/v) native polyacrylamide gels (39:1 acrylamide:bisacrylamide) and 
electrophoresed at room temperature in TBE buffer (45mM Tris borate at pH 8.3, 1.25mM 
Na2EDTA). After 3-6 h of electrophoresis, the gels were dried and complexes were visualized by 
phosphorimaging and quantified using Molecular Dynamics ImageQuant software.  The protein-
RNA complex was defined as the slowest migrating band on the gel, while free RNA was the 
lower band.  For calculating percent complex formation, the region on the gel from the slowest 
migrating complex to the free nucleic acid was considered as complex.  The percent complex 
was calculated as complex intensity divided by total intensity (complex plus free RNA).  Each 
gel shift was done in at least duplicate. 
Coupled In Vitro Transcription / Translation – Translation repression of the mRNA 
encoding the α and β subunits via CT binding was examined using a coupled in vitro 
transcription/translation system.  The EasyXpress Protein Synthesis System (Qiagen) was used 
following the manufacturer’s protocol with 1µg (~10 nM) plasmid or unlabeled mRNA as 
templates.  To examine the effect of CT on the expression of both genes simultaneously, pCZB5 
was used as a template.  The plasmid pCZB5 is an expression vector of similar construction to 
pGDM9 and contains the accA and accD genes in tandem with high levels of overexpression 
from those genes (Blanchard & Waldrop, 1998).  The ability of CT to attenuate translation of 
only the mRNA for the β subunit utilized the vector pGLW39, which contains only the accD 
gene cloned into pET28.  The proteins expressed from these templates were visualized by 
polyacrylamide gel electrophoresis, where each 50µl reaction contained 5µCi of [35S]L-
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Methionine.  The reaction mixtures were run on 5.0% (w/v) denaturing polyacrylamide gels 
(39:1 acrylamide:bisacrylamide, 2.5% SDS) at 2V/cm for 10-12h and dried.  Bands were 
visualized by phosphorimaging.  Each assay was done in triplicate. 
Detection of CT-RNA Interaction In Situ – Detection of CT binding to RNA in situ was 
accomplished using a fluorescence resonance energy transfer (FRET) assay with a CT β-
enhanced yellow fluorescent protein (eYFP) fusion protein as the donor and the RNA binding 
dye Sytox Orange (Molecular Probes) as the acceptor.  The gene for eYFP was amplified with 
primers eYFP5 and eYFP3, digested with XhoI and PacI, and cloned into equivalently digested 
pGDM9 and pGDM18 to generate pGDM24 and pGDM25, respectively.  The use of XhoI and 
PacI restriction sites eliminates the vector-encoded His6-tag and stop codon, while placing the 
stop codon following the coding region for the CT β-eYFP fusion protein.  Plasmid pGDM24 
contains wild-type CT-eYFP fusion and pGDM25 contains the quadruple cysteine variant of CT-
eYFP fusion.  E. coli BL21(DE3) harboring the plasmids pGDM24 and pGDM25 were grown at 
37°C until the A600 reached 0.7, at which point lactose was added to 28mM.  Samples of 100µl 
were collected just prior to induction with lactose, and every 0.5h afterward for 3h and flash 
frozen in liquid nitrogen.  Each sample was then thawed and divided equally into thirds.  The 
divided samples were either left as is, subjected to 0.3µg/µl RNase A (Qiagen), or 1.0U/µl 
DNase I for 0.5h at 37°C.  Sytox Orange is a high-affinity nucleic acid stain that readily enters 
cells with compromised membranes.  The dye was added to control and nuclease treated cells to 
a final concentration of 250nM.  There is considerable overlap of YFP emission and Sytox 
Orange absorption spectra; the Föerster distance (R0) is 5.6nm.  Spectra were collected using a 
Jasco FP-6300 spectrofluorometer equipped to hold a 3x3mm quartz cuvette.  500nm incident 
light was used to achieve sufficient FRET with minimal direct excitation of the acceptor.  
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Emission spectra were measured perpendicular to the incident light at 540 to 600nm to avoid the 
peak due to refracted light and to sufficiently span the absorption maximum of 573nm when the 
stain is bound to nucleic acid.  Each assay was done in triplicate. 
Results 
The Zinc Domain Is Required for Catalysis and Nucleic Acid Binding 
The Zn finger of CT is a member of the Cys4-type family, with the divalent metal 
coordinated in a tetrahedral fashion by four cysteine sulfhydryl groups (Figure 2.1).  Each of the 
cysteines (residues 27, 30, 46 and 49) coordinating the zinc atom were mutated to alanine 
individually followed by multiple mutations to remove two (double; C27A, C46A), three (triple; 
C27A, C46A, C49A), and all four (quadruple) cysteines. 
The effect of the cysteine mutations on enzymatic activity was assessed using a coupled 
enzyme assay where the reaction is run in the non-physiological direction in which malonyl-CoA 
and biocytin are the substrates.  The kinetic results indicate that mutation of individual cysteine 
residues 27, 46, and 49 decreases the Vmax only 8-11 fold whereas the Vmax for the C30A variant 
decreases by over 100 fold (Table 2.2).  Similar results were obtained with analogous mutations 
to the Cys4-type zinc finger of pea plastidic ACCase CT β (Kozaki et al, 2001).  Mutation of a 
single cysteine has only small effects on the Michaelis constant for both substrates, biocytin and 
malonyl-CoA.  None of the multiple site variants have measureable activity.  The results suggest 
that the Zn finger cysteines are not directly involved in substrate binding, but rather play a role in 
the catalytic step or product release. 
The decrease in activity as a result of mutating the cysteines in the zinc domain explains 
earlier observations that the thiol modifying reagent N-ethylmaleimide (NEM) inactivated 
carboxyltransferase and that the substrate malonyl-CoA protected against inactivation 
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Table 2.2 
Steady state kinetic parameters for wildtype CT and variants 
Construct Vmax (min-1) Km (biocytin, mM) Km (malonyl-CoA, µM) 
wildtype CT  211 ± 7 11.4 ± 0.4 40.0 ± 5.6 
C27A 22.8 ± 1.4 11.5 ± 0.5 53.2 ± 9.2 
C30A 1.5 ± 0.2 5.0 ± 1.1 20.2 ± 2.4 
C46A 18.8 ± 0.7 4.0 ± 0.7 72.2 ± 10.4 
C49A 26.7 ± 0.9 9.7 ± 0.6 106.8 ± 9.8 
C27/46A "double" 0   
C27/46/49A "triple" 0   
C27/30/46/49A "quadruple” 0   
The apparent maximal velocities and Michaelis constant for biocytin were obtained by varying 
biocytin while holding malonyl-CoA constant at 100µM.  The apparent Michaelis constant for 
malonyl-CoA was obtained by varying malonyl-CoA while holding biocytin constant at 20mM.  
The standard errors on Vmax and Km were determined from the nonlinear regression analysis.   
 
 (Blanchard & Waldrop, 1998).  Reaction of NEM with the most active single-site variants 
(C27A, C46A, andC49A) showed less susceptibility to NEM when normalized and compared to 
wildtype (data not shown), which is consistent with NEM modifying these cysteine residues in 
the zinc domain and in turn affecting enzymatic activity.  In addition, the location of the zinc 
domain on the β subunit (which contains the malonyl-CoA binding site) is consistent with 
malonyl-CoA protecting against inactivation. 
Mutation of the cysteines in the zinc domain not only affected catalytic activity but also 
nucleic acid binding.  An electrophoretic mobility shift assay (EMSA) was used to assess the 
effect of the mutations on CT binding to DNA (Figure 2.2).  CT with single substitutions at 
positions 27, 46, and 49 appear to exhibit diminished DNA-binding capacity as evidenced by 
complex dissociation during electrophoresis while the C30A variant and the multiple cysteine 
variants fail to form stable complexes with the DNA.  Thus, the zinc finger cysteines are required 
for DNA-binding, as expected. 
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Figure 2.2  An ethidium bromide-stained 0.8% agarose gel image of DNA binding by CT and 
variants.  Lanes 1-9 contain an 800 bp linear dsDNA with the following proteins: 1, no protein; 
2, wtCT; 3, C27A; 4, C30A; 5, C46A; 6, C49A; 7, double variant; 8, triple variant; 9, quadruple 
variant. 
 
Substitution of the cysteines likely altered the electrostatic structure of the zinc finger, 
resulting in the loss of zinc coordination.  The effect of the mutations on the molar zinc content 
was determined using atomic absorption spectroscopy.  Wildtype CT had 2 zinc atoms per CT 
tetramer as predicted from the structure.  CT with single-site substitutions at cysteines 27, 46, 
and 49 contained 1.2-1.3 zinc atoms per CT tetramer while the C30A variant had only 0.76 zinc 
atoms per CT tetramer.  CT variants with multiple substitutions show progressively lower 
occupancies decreasing from 0.52 to 0.29 molar ratios.   Circular dichroism spectroscopy was 
used to determine if the mutations had an effect on the overall secondary structure.  CT variants 
C30A, C46A, and C49A show spectra similar to wildtype CT (Figure 2.3).  The spectra for the 
Complex 
DNA 
50 
 
C27A and variants with double and triple substitutions show successive changes in the 205 to 
215nm range; the spectrum of CT lacking all four cysteines has much more extensive changes 
ranging from 205 to as far as 240nm.  The effects of the mutations on catalysis and nucleic acid 
binding are likely due to loss of the zinc atom and alteration in secondary structure and they 
clearly demonstrate that the zinc domain is the structural feature of CT that links nucleic acid 
binding with catalysis. 
 
Figure 2.3  Circular dichroism spectra of wildtype CT and variants. 
 
Carboxyltransferase Binds Preferentially to the α  and β  Subunit mRNA 
Earlier DNA binding studies showed that DNA binding was non-specific and cooperative 
with half-maximal saturation of about 1µM for a variety of DNA sequences, indicating that DNA 
binding was not likely to be the physiological role of the zinc domain of carboxyltransferase 
(Benson et al, 2008).  However, considering that the closest structural homolog of the 
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carboxyltransferase Zn-domain is the zinc domain from the 50S ribosomal protein L37Ae (Bilder 
et al, 2006), the ability of carboxyltransferase to bind RNA was investigated.  Four different 
types of RNA were tested for their ability to inhibit formation of the CT-DNA complex.  The 
RNA molecules considered included mRNA coding for the α subunit, mRNA coding for the β 
subunit, a total RNA extract from E. coli, and tRNA from Saccharomyces cerevisiae.  All four 
types of RNA were found to inhibit formation of the CT-DNA complex (data not shown).  
Notably, a qualitative comparison of the data showed that mRNA coding for the α and β 
subunits inhibited complex formation more effectively.  A transcript including the α subunit 
mRNA starting 213 nt upstream of the AUG through the end of the structural gene was therefore 
used in an EMSA (Figure 2.4).  In contrast to the sigmoidal binding isotherm obtained for 
carboxyltransferase binding to DNA, fractional carboxyltransferase-RNA complex formation is 
best fit to a hyperbolic curve, yielding a half-maximal binding constant (Kd) of 145 ± 9nM, 
which is about 7-fold lower than the half-maximal saturation for DNA binding.  When the data 
were fitted to the Hill equation a Hill coefficient of ~1 was calculated, indicating a lack of 
cooperativity (not shown).  Moreover, the data were also analyzed according to Hensley et al. 
(1981), which uses various linear transformations to detect a low degree of positive 
cooperativity.  These analyses also indicate that the degree of cooperativity for subunit mRNA 
binding to carboxyltransferase is either very small or nonexistent.  The tighter binding and 
hyperbolic binding isotherm for carboxyltransferase mRNA complex formation may suggest 
preferred binding to specific sites. 
The Binding Site Is Within the α  and β  Subunit mRNA Coding Region 
To determine the region(s) of mRNA to which CT is binding, a series of linear DNA 
templates were constructed from which mRNAs of various lengths were transcribed using runoff 
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Figure 2.4  (A) Electrophoretic analysis of the transcript from CT α subunit titrated with CT.  
(A) All lanes contain 50 fmol 32P-labeled mRNA, while lanes 2 - 15 contain 1.0, 5.0, 10, 25, 40, 
55, 70, 85, 100, 200, 300, 400, 500, and 600nM CT.  (B) Binding isotherm for CT binding to the 
transcript from CT α subunit.  The points represent averages from triplicate measurements.  The 
error bars shown are the standard deviation.  The curve represents the best fit of the data to 
equation 1.  No conclusions about the stoichiometry of binding can be made from this curve. 
 
transcription (Figure 2.5).  Electrophoretic mobility shift assays were used to measure the Kd for 
each RNA construct binding to wildtype CT.  Starting with the natural transcription start site of 
accA and ending with the stop codon, the 1183 nt transcript yielded a Kd of 136 ± 10 nM.  
Systematic truncation of the 3′ end by successive ~300 nt deletions generated a 886 nt CT α 
53 
 
RNA to which CT bound more tightly with a Kd of 48 ± 8 nM, while further truncation resulted 
in a marked decrease in the ability of CT to bind the RNA.  The shortest transcripts consisting 
only of the 5′ untranslated region (UTR) yielded no complex on incubation with CT.   To 
confirm that the 5′ UTR region is not involved in CT binding, similar sized templates were made 
without the 5′ UTR and tested for CT binding.  The longest transcript lacking the 5′ UTR but 
containing the entire α subunit coding region (966 nt) bound to CT with a Kd of 250±20nM.  The 
684 nt transcript representing a 3′-truncation yielded a CT-RNA complex, however the fractional 
complex could not be measured due to the existence of numerous CT-RNA complexes co-
migrating with free RNA.  The shortest transcript (328 nt) showed no ability to bind to CT. 
A series of templates similar to the ones described above for accA were also made for the 
accD coding region (Figure 2.5).  The 5′ UTR was excluded from the accD transcripts because it 
was found not to play a role in CT binding to accA mRNA.  The transcript (912 nt) containing 
the entire open reading frame of CT β had a Kd of 290 ± 20nM, while truncating 228 nt from the 
3′ end (684 nt transcript) resulted in a decrease in Kd to 83±9nM.  This pattern for the two 
longest transcripts was also observed with accA. Moreover, just as with accA, shorter transcripts 
of accD bound CT only poorly. 
Comparison of the α and β subunit mRNA regions required for CT binding reveals a 
striking similarity. For both subunits, 684 nt fragments beginning at the start sites were optimal.  
Within this sequence were 356 nt in α mRNA, and 335 nt in β mRNA that translate into regions 
of higher amino acid sequence homology (41%) compared to the alignment of the entire protein 
sequence (30%).  This region of the mRNA of the α and β subunits will be hereafter referred to 
as the “symmetry box.”  All RNA constructs from either subunit that excluded this region lacked 
the ability to bind CT, suggesting its contribution to enzyme recognition.  Two additional 
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Figure 2.5  mRNA in vitro transcription products. 
 
templates were constructed consisting of only the regions from each gene representing this 
symmetry box to determine whether these regions are not only necessary, but sufficient for CT 
binding.  Neither transcript had any affinity for CT, indicating that regions upstream of the 
symmetry box are also necessary for CT binding.  The upstream region and the symmetry box 
must be connected for binding to CT because simply combining the two regions individually did 
not result in CT binding for either mRNA (data not shown). 
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Carboxyltransferase Inhibits Translation of α  and β  Subunit mRNA 
If CT binds to the mRNA coding for the α and β subunits, then does CT binding inhibit 
translation of the mRNA?  This question was addressed using an in vitro coupled 
transcription/translation reaction.  The mRNA for both α and β subunits was generated by 
transcription from a plasmid containing the genes for both subunits.  The reaction was carried out 
in the presence of 35S-labeled methionine, and products separated on a polyacrylamide gel and 
visualized by phosphorimaging (Figure 2.6).  Increasing amounts of unlabeled wildtype CT 
added to the reaction prior to initiation by addition of plasmid progressively decreased the in 
vitro synthesis of CT (Figure 2.6, lanes 6-10).  The decrease in expression in the presence of 
unlabeled CT is not due to an inhibition of transcription because CT also inhibited translation 
when an mRNA transcript was used to initiate expression (Figure 2.6A, lanes 3 and 4).  The 
inhibition of translation was partially reversed by the addition of the substrate acetyl-CoA, 
indicating a reversible competition between mRNA and substrate and consistent with the notion 
that nucleic acid binding and catalysis are mutually exclusive (Figure 2.6A, lanes 11-15).  To 
ensure that CT binding to α mRNA does not affect translation of the β subunit, the ability of CT 
to inhibit translation of the β subunit mRNA was examined.  The coupled 
transcription/translation reaction from a plasmid containing only the accD gene showed that CT 
does indeed inhibit translation of the β subunit mRNA (Figure 2.6B, lanes 4-7).  The inhibition 
was again relieved by the substrate acetyl-CoA (Figure 2.6B, lanes 8-11).  The inhibition of 
translation was specific for the mRNA coding for the α and β subunits because CT did not 
inhibit translation of the gene coding for the 32 kDa elongation factor EF-Ts which was provided 
as a control in the in vitro coupled transcription/translation reaction (Figure 2.6C).  Reinforcing 
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the role of the zinc domain in nucleic acid binding, addition of the quadruple variant of CT had 
no effect on the level of translation (data not shown.) 
To confirm that acetyl-CoA relieved inhibition of translation by reversible competition 
between mRNA and the substrate acetyl-CoA, inhibition of CT-RNA complex formation by 
acetyl-CoA was examined.  The transcript (912 nt) containing the entire open reading frame of 
CT β was incubated with 166 nM CT and increasing amounts of acetyl-CoA (Figure 2.7A).  
With increasing [acetyl-CoA], a concomitant decrease in CT-RNA complex formation is evident.  
This demonstrates reversible competition between mRNA and substrate.  Conversely, since the 
substrate acetyl-CoA inhibited the binding of CT to RNA, and given that catalysis and nucleic 
acid binding in CT are linked through the zinc domain, RNA should inhibit catalysis as well.  An 
1183 nt CT α mRNA was found to inhibit CT activity in a dose-dependent manner, with nearly a 
4-fold drop in activity at 90 nM (Figure 2.7B).  As a control, CT retained greater than 80% 
activity in the presence of a 90 nM 1040 nt mRNA coding for EF-Ts (Figure 2.7B); that EF-Ts 
inhibits CT activity at higher concentrations is consistent with the nonspecific binding to nucleic 
acids reflected in DNA binding.  These results confirm that mRNA binding to CT inhibits 
enzymatic activity. 
Carboxyltransferase-RNA Interaction Occurs In Situ 
CT binds to RNA in vitro, but does CT interact with RNA in the context of a cell?  To 
address this issue, a FRET (fluorescence resonance energy transfer) assay was used.  The assay 
is based on the work of Lorenz (2009) and utilized eYFP (enhanced yellow fluorescent protein) 
fused to wildtype or the quadruple variant of CT β as the donor and the nucleic acid stain Sytox 
Orange as the acceptor.  Cells containing plasmids where the genes for CT α and either wildtype 
CT β fused to eYFP or quadruple variant CT β fused to eYFP were induced to express the CT α 
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Figure 2.6  5% denaturing polyacrylamide gels of in vitro coupled transcription/translation 
reactions expressing 35S-labeled proteins.  (A) Lane 1, no DNA template.  Lane 2, positive 
control test plasmid encoding the 32kDa elongation factor EF-Ts protein.  Lane 3, polycistronic 
mRNA generated in vitro from pCZB5 plasmid showing CT α (37kDa) and CT β (33kDa).  Lane 
4, same as lane 3 with the addition of 166nM unlabeled wildtype CT to the 
transcription/translation reactions.  Lanes 5-15 contain 1µg (~10nM) pCZB5 plasmid.  Lanes 5-
10 contain 0, 63, 125, 250, 500, and 1000 nM unlabeled wildtype CT.  Lanes 10-15 contain 1µM 
unlabled wildtype CT and acetyl-CoA at 0, 88, 175, 350, 700, and 1400µM.  (B) Lane 1, no 
DNA template.  Lane 2, positive control test plasmid showing a 32kDa protein.  Lane 3-11 
contain 1µg (~10nM) pGLW39 plasmid.  Lanes 3-7 contain 0, 63, 125, 250, and 1000nM 
unlabeled wildtype CT.  Lanes 7-11 contain 1µM unlabeled wildtype CT and acetyl-CoA at 0, 
175, 350, 700, and 1400µM.  (C) Lane 1, no DNA template.  Lanes 2-8 contain positive control 
test plasmid as in panel A, lane 2.  Lanes 3-8 contain 31, 63, 125, 250, 500, and 1000nM 
unlabeled wildtype CT. 
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Figure 2.7  (A) Electrophoretic analysis of the transcript from CT β subunit titrated with CT.  
All lanes contain 50 fmol 32P-labeled mRNA, lane 1 contains only mRNA while lanes 2 - 14 
contain 166nM CT and acetyl-CoA at 0, 20, 50, 100, 200, 300, 400, 500, 600, 750, 1000, 2000, 
and 4000µM.  (B) RNA inhibition of CT activity.  Circles represent averages from triplicate 
measurements for reactions containing the 1040 nt EF-Ts transcript at 0, 11.3, 22.6, 45.3, and 
90.6 nM.  Triangles represent averages from triplicate measurements for reactions containing the 
1183 nt CT α transcript at 0, 11.6, 23.2, 46.4, and 92.8 nM. The error bars shown are the 
standard deviation.  Note that enzymatic reactions contain only 1 mM KCl, conditions under 
which the affinity of CT for RNA is higher than that determined from EMSA assays. 
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and CT β-eYFP fusion proteins.  After 0-3 h, samples were freeze-thawed followed by various 
nuclease digestions.  Sytox Orange was added to the treated cells and fluorescence was measured 
to determine proximity of CT β-eYFP to nucleic acid-bound stain.  As shown in Figure 2.8 a 
FRET signal was observed only after induction of protein expression (blue trace).  The maximal 
signal occurred 1 h after induction with no change up to 3 h post-induction.  Little to no signal 
was detected prior to induction (purple trace).  Since Sytox Orange can also bind to DNA, cells 
were treated with DNase or RNase in order to confirm the signal is a result of RNA interaction.  
Treatment with DNase I had little effect on the fluorescence signal (red trace); however, 
digestion with RNase A attenuated the signal to near pre-induction levels (green trace).  The 
quadruple variant-eYFP fusion protein showed no FRET signal consistent with its inability to 
bind nucleic acids (orange trace).  These data indicate that in situ the primary nucleic acid  
 
Figure 2.8  FRET emission scan showing absorption peak generated by incident light at 500nm.  
Blue trace, wildtype CT fused to eYFP, 1h post-induction, not subjected to nucleic acid 
digestion.  Purple trace, wildtype CT fused to eYFP, pre-induction, not subjected to nucleic acid 
digestion.  Red trace, wildtype CT fused to eYFP, 1h post-induction, treated with DNase.  Green 
trace, wildtype CT fused to eYFP, 1h post-induction, treated with RNase.  Orange trace, 
quadruple variant CT fused to eYFP, 1h post-induction, not subjected to nucleic acid digestion. 
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binding target of CT is RNA.  While these results show that CT prefers to bind to RNA over 
DNA in the cell, they do not address the question of RNA specificity.  As a control, the CT β-
eYFP fusion protein was expressed, purified, and shown in vitro to exhibit fluorescence with 
500nm incident light.  The emission peak at 547nm drops significantly with a concomitant 
appearance of a new emission peak at 574nm upon addition of Sytox Orange to the sample (data 
not shown).  This indicates a functional donor/acceptor pair for FRET with an excitation 
wavelength of 500nm. 
Discussion 
Enzymatic Activity and Translational Repression Require the Zinc Domain 
Site-directed mutagenesis of the zinc domain conclusively establishes that it is the 
structural link between nucleic acid binding and catalysis.  The coupling of nucleic acid binding 
to catalysis implies a selective pressure to maintain the zinc domain on the β subunit and that the 
ability to bind nucleic acids has a specific purpose; consistent with this inference, we find that 
CT binds RNA in situ.  Notably, in vitro analyses demonstrate that CT preferentially binds the 
mRNA encoding its own α and β subunits, implying the existence of an uncommon regulatory 
mechanism. 
The binding of CT to the mRNA coding for the α and β subunits inhibited translation in a 
dose-dependent manner, while the substrate acetyl-CoA inhibited RNA binding and relieved the 
inhibition of translation also in a dose-dependent manner.  Consistent with the coupled nature of 
nucleic acid binding and catalysis by CT, the mRNA also inhibited catalysis.  These findings 
indicate a physiological role for the zinc domain in regulating not only production of the α and β 
subunits of CT, but also its enzymatic activity.  The basic premise of the model of regulation 
illustrated in Figure 2.9 is that in bacteria, fatty acids are only used for membrane biogenesis, 
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hence carboxyltransferase is only needed when nutrients are abundant.  In contrast, during the 
stationary phase of E. coli growth where nutrients are limited, carboxyltransferase would act as a 
“dimmer switch” on the expression of the α and β subunits by binding to the mRNA and 
inhibiting translation.  Reciprocally, RNA binding by CT renders it catalytically inactive, 
limiting unneeded and wasteful conversion of acetyl-CoA to malonyl-CoA.  During the growth 
phase when nutrients are abundant, the level of acetyl-CoA would increase dramatically and 
compete with the mRNA for binding to carboxyltransferase.  This alleviates both the inhibition 
of catalytic activity and the repression of translation characteristic of stationary phase, leading to 
increased levels of CT and ultimately fatty acids.  The levels of acetyl-CoA in E. coli during the 
log phase (600µM) and stationary phase (20µM) (Takamura & Nomura, 1988) are in accord with 
the data in Figure 2.6A, because relief of translational repression was observed at 350µM acetyl-
CoA whereas very little protein production was observed at 88µM acetyl-CoA.  This model of 
regulation is also consistent with reports that levels of the mRNA coding for the α and β subunits 
do not change appreciably between the log and stationary phases (Sundararaj et al, 2004; 
Selinger et al, 2000). 
The model of regulation in Figure 2.9 also provides a plausible explanation for how the 
cell maintains stoichiometric amounts of the α and β subunits.  Instead of transcriptional control 
of gene expression of the genes for the α and β subunits, bacteria appear to utilize translational 
repression where CT binds to the mRNA for both of its subunits. 
The mechanism of gene regulation proposed here is not without precedent.  For example, 
thymidylate synthase from both E. coli and humans contains a Cys4-type zinc-binding motif and 
binds its own mRNA within the protein-coding region, repressing translation (Voeller et al, 
1995; Chu et al, 1993; Chu et al, 1991).  Also, it is important to note that this type of regulation 
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Figure 2.9  Proposed mechanism for autoregulation of CT enzymatic activity and mRNA 
translation.  The RNA-binding and catalytic functions of CT are sensitive to the metabolic state 
of the cell.  During stationary phase when de novo fatty acid synthesis is unneeded, glucose and 
thus acetyl-CoA levels are low, allowing CT to bind the mRNA for its subunits, attenuating 
expression of the enzyme as well as enzymatic activity on remaining acetyl-CoA stores. During 
log phase growth membrane biogenesis is needed.   Glucose is abundant, increasing the 
availability of acetyl-CoA for fatty acid synthesis.  Acetyl-CoA binds to CT permitting 
translation of the mRNA for the α and β subunits. This "dimmer switch" model gives the cell a 
means of rapid response to changes in cellular metabolic state. 
 
is not found in eukaryotic carboxyltransferase because the α and β subunits are fused to one 
another as well as to the BC and BCCP components to form one polypeptide chain and because 
the zinc domain is absent (Bai et al, 1986).  The one exception to the multidomain homomeric 
ACCase found in eukaryotes is the heteromeric ACCase found in plastids.  The chloroplast 
ACCase of all plants except for the grasses (Graminae) consists of the same four subunits as E. 
coli ACCase, but their genetic origins are different (Nikolau et al, 2003).  The BC, BCCP, and 
CT α peptides originate from nuclear-encoded genes and are shuttled to the chloroplast (Bao et 
al, 1997; Sun et al, 1997; Ke et al, 2000).  The CT β protein, however, is expressed from a 
64 
 
chloroplast-encoded gene, and like the E. coli accD gene, encodes a Cys4-type zinc-binding 
domain, which is consistent with the theory that chloroplasts evolved from bacterial symbiosis 
(Ke et al, 2000).  Perhaps the zinc domain in chloroplast CT β binds to the β mRNA to regulate 
translation in a manner similar to the model presented here for E. coli CT. 
A Symmetry-Based Model 
The fundamental tenet of the gene regulation model presented in Figure 2.9 rests on the 
ability of CT to bind the mRNA encoding both α and β subunits.  The molecular basis of how it 
does so is rooted in the symmetry of the chemical mechanism and three-dimensional structure of 
CT.  Transfer of the carboxyl group from carboxybiotin to acetyl-CoA involves formation of 
enolate or enolate-like anions in both carboxybiotin and acetyl-CoA.  To this end, both the α and 
β subunits have evolved tertiary folds that stabilize oxyanions.  Acetyl-CoA binds to the β 
subunit, while carboxybiotin binds to the α subunit and the tertiary structure of both the α and β 
subunits contain a similar α/β spiral core of two β-sheets surrounded by α-helices suggesting a 
gene duplication event.  This type of fold places carboxyltransferase in the crotonase superfamily 
of enzymes whose members all catalyze reactions that generate enolate anions (Holden et al, 
2001; Hamed et al, 2008).  Within the spiral core of both the α and β subunits of CT are 
oxyanion holes formed by main chain amides from glycine residues (Bilder et al, 2006).  The 
regions of the mRNA for the α and β subunits that bind to CT also reveal a symmetrical pattern.  
CT binds only to the coding region of the mRNA of the α and β subunits, a region that included 
the symmetry box, which corresponds to the spiral core of the tertiary structure containing the 
oxyanion holes.  While the symmetry box is required for CT binding, it is not sufficient.  The 
mRNA upstream of the symmetry box is also needed for binding, probably to achieve the proper 
three-dimensional fold of mRNA to interact with CT.  This observation is consistent with the 
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notion that mRNA sequences close to the start site are more likely to be involved in regulatory 
events.  Thus, while there are numerous examples of how the chemistry of a reaction drives the 
evolution of enzyme structure, the results presented here for carboxyltransferase not only suggest 
a physiological role for the zinc domain but extend the concept of chemistry directing enzyme 
evolution to also include directing the mechanism of gene regulation. 
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CHAPTER 3 
MATHEMATICAL MODELING OF NEGATIVE FEEDBACK REGULATION BY 
CARBOXYLTRANSFERASE 
 
Introduction 
Negative feedback plays a prominent role in biological processes as a means of 
regulation.  This type of regulation provides biological systems with a simple yet effective 
method for altering concentrations of metabolites in response to dynamic environmental 
conditions.  Classic examples of negative feedback in metabolic biochemistry include the 
inhibition of phosphofructokinase by ATP in the glycolytic pathway (Schirmer & Evans, 1990); 
while in pyrimidine biosynthesis, the end product of the pathway, CTP, inhibits aspartate 
transcarbamoylase, which catalyzes the first committed step (Schachman, 1993).  In fact, Gerhart 
and Pardee (1962), who first described the negative feedback regulation of pyrimidine 
biosynthesis, pointed out there are certain features of negative feedback that make it particularly 
attractive for biological regulation.  For instance, pathways under the control of negative 
feedback tend to be self-limiting in terms of product formation, while systems involved in 
positive feedback regulation exhibit tendencies to reach extremes.  In a biological context, 
negative feedback loops enforce bounds on the range over which the concentrations of molecules 
are allowed to vary, avoiding waste of energy resources on unneeded end products (Gerhart & 
Pardee, 1962).  This concept of energy conservation in negative feedback regulation was recently 
found to play a prominent role in bacterial fatty acid synthesis (Meades et al, 2010).   
The first committed step in the biogenesis of fatty acids in all organisms is the biotin-
dependent carboxylation of acetyl-CoA to form malonyl-CoA, catalyzed by acetyl-CoA 
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carboxylase (ACCase).  The overall reaction takes place in two separate half-reactions shown in 
Scheme 3.1.  The first half-reaction is catalyzed by biotin carboxylase, where ATP is used to 
 
Scheme 3.1 
activate bicarbonate for carboxylation of biotin.  The natural substrate is the biotin carboxyl 
carrier protein (designated as Enzyme-biotin in Scheme 3.1).  The second half-reaction, 
catalyzed by carboxyltransferase, transfers the activated carboxyl group from carboxybiotin to 
acetyl-CoA to form malonyl-CoA.  In contrast to the single, multi-domain polypeptide of 
eukaryotes, Escherichia coli encodes separate polypeptides for biotin carboxylase (BC), a biotin 
carboxyl carrier protein (BCCP), and an α2β2 heterotetrameric carboxyltransferase (CT) (Cronan 
& Waldrop, 2002).  The genes coding for the α and β subunits of CT are on opposite sides of the 
E. coli chromosome (Blattner et al, 1997) and their expression is not regulated at the 
transcriptional level (Li & Cronan, 1992).  Thus, how does a bacterial cell regulate expression of 
the genes coding for the α and β subunits of CT in order to achieve stoichiometric levels of the 
two proteins? 
The crystal structures of both E. coli (PDB: 2f9y) and Staphylococcus aureus (PDB: 2f9i) 
CT revealed a Cys4-type zinc ribbon motif on the β subunit (Bilder et al, 2006).  The zinc 
domain on the β subunit was found to mediate CT binding to the mRNA coding for both the α 
and β subunits (Meades et al, 2010).  This CT/mRNA interaction inhibited translation while the 
substrate acetyl-CoA relieved the inhibition of translation.  The zinc domain was also required 
for enzymatic activity, which was inhibited by mRNA binding.  Therefore, enzymatic activity 
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and mRNA binding are coupled in a reciprocal fashion leading to a negative feedback 
mechanism for regulation of enzymatic activity and gene expression; see Figure 3.1 (Meades et 
al, 2010).  As illustrated in Figure 3.1, when acetyl-CoA levels are low, CT binds to its own 
mRNA and acts as a “dimmer switch” to inhibit translation as well as its own activity.  Since 
bacteria synthesize fatty acids for the sole purpose of membrane biogenesis, this allows CT 
activity and production to be limited in stationary phase growth.  During growth in log phase, the 
increase in acetyl-CoA levels displaces CT from its mRNA, thereby allowing for translation and 
enzymatic activity.  This biochemical negative feedback mechanism serves two important 
functions.  First, it allows a bacterial cell to only synthesize CT and ultimately fatty acids during 
the growth phase, when they are needed.  Second, it provides a mechanism at the translational 
level for stoichiometric production of the α and β subunits of the enzyme. 
 
Figure 3.1.  Model for negative feedback regulation of CT activity and translation. 
While the model in Figure 3.1 is an attractive negative feedback mechanism for 
regulating gene expression and enzymatic activity, it is nonetheless a composite of several 
individual observations (Meades et al., 2010).  This is the traditional reductionist approach to 
understanding biological mechanism where each component is characterized separately and then 
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a static model is assembled.  However, biological processes, including the model in Figure 3.1, 
are dynamic where all the components work in concert to produce and regulate a biological 
effect.  One approach for analyzing a multicomponent process is to quantitatively assess how all 
the components vary with time.  Examples of this approach include computational modeling of 
positive feedback in blood coagulation (Khanin & Semenov, 1989), negative feedback by the 
pentose phosphate pathway (Calvin cycle) in photosynthesis (Pettersson & Ryde-Pettersson, 
1988), kinetic analysis of the multienzyme complexes pyruvate dehydrogenase and α-
ketoglutarate dehydrogenase (Najdi et al, 2010), as well as mathematical analysis of metabolite 
concentration (Shinar & Feinberg, 2010).  In this paper, a mathematical model for the negative 
feedback mechanism in Figure 3.1 is described.  Numerical simulations of the mathematical 
model are then compared to experimental results obtained with an experimental design that 
closely mimics the in vivo system.  The rigorous quantitative analysis of the proposed model 
illustrates that each of the components of the system acts in a dynamic, concerted fashion to 
ultimately regulate fatty acid biosynthesis in E. coli. 
Materials and Methods 
Reagents – Restriction enzymes and T4 DNA ligase were from New England Biolabs.  
Pfu Turbo DNA polymerase was from Stratagene.  The cloning vector pGEM-11zf was from 
Promega.  The expression vector pET28b and the E. coli host strains NovaBlue and BL21(DE3) 
were from Novagen.  Primers were synthesized by MWG Biotech.  In vitro transcription kit was 
from Ambion.  T7 in vitro transcription/translation kit was from Qiagen.  [α-32P]UTP 
(3000Ci/mmol) was from PerkinElmer.  Biotinylated BCCP was a gift from Pfizer, Inc.  His-
binding cartridges and all other reagents were from Sigma. 
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Site-directed Mutagenesis – Glycine 206 of the E. coli CT α subunit was mutated to 
valine using the method of overlap extension (Ho et al, 1989).  Complementary oligonucleotides 
G206V5 (5´ AAGGTGGTTVTGTCGGTGCGCTGG 3´) and G206V3 (5´ 
CCAGCGCACCGACAGAACCACCTT 3´) containing specific alterations in the nucleotide 
sequence were used to generate two DNA fragments having overlapping ends.  These fragments 
were combined and used as the template in a subsequent PCR reaction using primers ACCA1 (5´ 
GGAATTCCATATGAGTCTGAATTTCCTTGATTTTGAA 3´) and ACCA2 (5´ 
CCGCTCGAGTTCTCCTTACGCGTAACCGTAGCTCATCAGGCG 3´) to generate the full-
length accA gene with the desired G206V mutation.  The PCR product was digested with EcoRI 
and XhoI and ligated into pGEM-11zf cut with the same two restriction enzymes to form 
plasmid pNKT18.  The wildtype accD gene encoding the CT β subunit as described by 
Blanchard and Waldrop (1998) was PCR amplified and digested with the restriction enzymes 
XhoI and BamHI and ligated in similarly digested pNKT18 to generate the plasmid pNKT19.  
The construct was sequenced to confirm the mutation and verify there were no other changes.  
The plasmid pNKT19 was then digested with NdeI and BamHI and ligated into the equivalently 
digested expression vector pET28b to produce pNKT22.  This plasmid contains the αG207V 
variant and wildtype β subunits in a mini-operon under the control of a lac operon. 
Expression and Purification – Plasmid encoding wildtype CT (pGDM9) (Meades et al, 
2010) and the αG207V variant / wildtype β (pNKT22) were transformed independently into E. 
coli BL21(DE3) and grown as described by Blanchard and Waldrop (1998) with the exceptions 
noted by Meades et al (2010). 
Enzymatic Assay – ACCase activity was measured with a spectrophotometric assay in 
which the production of inorganic phosphate was coupled to purine nucleoside phosphorylase 
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(PNPase) in the conversion of 7-methyl-6-thioguanosine (MESG; Berry and Associates) to 7-
methyl-6-thioguanine (Miller et al, 2009).  The 0.5 ml reaction mixture contained 5 mM MgCl2, 
100 mM KCl, 50 mM Hepes, pH 8.0, 0.1 mg/ml BSA, 0.05 U/ml PNPase, 150 µM MESG, 80 or 
200 µM ATP, 0.5 mM sodium citrate, 100 µM acetyl-CoA, and protein components BC, CT, and 
biotinylated BCCP in final concentrations of 325 nM, 271 nM, and 1.12 or 2.57 µM, 
respectively.  Seven-methyl-6-thioguanine formation was followed spectrophotometrically at 
360nm using a Uvikon 810 (Kontron Instruments) spectrophotometer interfaced to a computer 
equipped with a data acquisition program. 
Data analysis – The kinetic parameters Km and Vm were determined by nonlinear 
regression analysis, where the initial velocites versus the substrate concentration were fitted to 
the Michaelis-Menten equation using the programs of Cleland (1979).  
 
In Vitro Transcription and RNA Electrophoretic Mobility Shift Assay – A cell-free 
extract was used to produce mRNA using the MEGAscript Kit (Ambion) following the 
manufacturer’s protocol with 0.2 µg PCR product as the template.  Radiolabeled RNA was 
generated as described by Meades, et al (2010).  Seven µl of resultant mRNA was added to each 
10 µl reaction, with αG206V CT titrated from 0 to 1 µM in the remaining 3 µl.  For the 
inhibition of RNA binding, acetyl-CoA was titrated from 0 to 4.0 mM.  Reactions were 
incubated on ice for 30 minutes. Samples were loaded with the power on onto prerun 5.0% (w/v) 
native polyacrylamide gels (39:1 acrylamide:bisacrylamide) and electrophoresed at room 
temperature in TBE buffer (45mM Tris borate at pH 8.3, 1.25mM Na2EDTA). After 3-6 h of 
electrophoresis, the gels were dried and visualized by phosphorimaging and quantified using 
Molecular Dynamics ImageQuant software.  For unlabeled RNA, each 20 µl reaction contained 
7.5 mM ATP, CTP, GTP, UTP, and 0.2 µg PCR product as the template.  The resultant mRNA 
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was purified according to the manufacturer’s instructions with the MEGAclear Kit (Ambion) and 
eluted in 100 µl.  Unlabeled RNA was quantified by measuring absorbance at 260 nm. 
In Vitro Translation – Translational repression of the mRNA encoding the α and β 
subunits via CT binding was examined using a coupled in vitro transcription/translation system.  
The EasyXpress Protein Synthesis System (Qiagen) was used following the manufacturer’s 
protocol with the exception that 125 nM of each wildtype α and β subunit mRNA were used as 
templates, bypassing the transcription half of the system.  The 50 µl reactions were incubated at 
37°C for 5, 10, or 60 minutes followed by addition of 0.1µg/µl RNase A (Qiagen) and held for 
15 minutes at 25°C.  The proteins expressed from these templates were detected by the PNPase 
assay using the RNase-treated samples as the source of CT.  To convert the initial velocity 
measurements into CT concentrations, a standard curve was generated using known 
concentrations of CT.  The ability of CT to repress translation of mRNA was determined by 
addition of 10 nM – 10 µM αG206V CT to the in vitro translation reaction.  As the αG206V CT 
variant is catalytically inactive, the PNPase assay was again used to detect translation of 
wildtype CT enzyme following RNase treatment.  Initial velocites measured from in vitro 
translated CT were converted to CT concentrations by use of a standard curve generated from 
known CT concentrations and cooresponding measured initial velocities. 
Computer Simulations – All computer simulations were conducted in MATLAB Version 
7.8.0 using the built-in, ordinary differential equation solver, ode15s.  All the solver options were 
kept at their default values except for the absolute tolerance error (AbsTol) and the relative 
tolerance error (RelTol) which were set to 10-19 and 10-9, respectively. 
Experimental System 
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The experimental system used to evaluate the mathematical model is based on an assay 
originally developed by Pfizer for high-throughput screening of inhibitors of the overall ACCase 
reaction (Miller et al, 2009).  As shown in Scheme 3.1, the BCCP protein recycles between the 
two half reactions catalyzed by BC and CT just as it does in a bacterium. The overall reaction 
results in the generation of inorganic phosphate, which is measured spectrophotometrically via 
coupling to purine nucleoside phosphorylase (PNPase).  This coupling enzyme converts 7-
methyl-6-thioguanosine to 7-methyl-6-thioguanine and the change in absorbance is measured at 
360 nm. 
To experimentally determine the effect of CT subunit mRNA on enzymatic activity in the 
context of all the components of ACCase, the PNPase-coupled assay was first be validated as an 
accurate measure of enzymatic activity. The apparent maximal velocity and Michaelis constant 
for acetyl-CoA were obtained by varying acetyl-CoA while holding the other two substrates ATP 
and BCCP constant at 80 µM and 2.57 µM, repsectively. The kinetic results gave a Vmax of 
230±4 min-1 and a Michaelis constant for acetyl-CoA of 36.7±2.7 µM.  These kinetic parameters 
are consistent with values determined previously for CT in the absence of BC and BCCP (Vmax of 
211±7 min-1 and Km for malonyl-CoA1 of 40.1±5.6 µM (Meades et al, 2010)), indicating that the 
affinity of CT for the acyl-CoA substrate is unaltered by the presence of BC and BCCP.  It is 
interesting to note that varying the concentration of BC at a constant amount of CT had no effect 
on the velocity of the reaction, suggesting that the CT-catalyzed half-reaction is the rate-limiting 
step in the ACCase reaction. More importantly, using the PNPase-coupled assay, mRNA coding 
for both the α and β subunits of CT inhibited CT activity just as it did in the CT-specific assay 
                                                 
1 In the CT-specific assay, activity was measured in the reverse, or non-physiological, direction using malonyl-CoA 
and biocytin as substrates, and acetyl-CoA and carboxybiocytin as products. 
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(Meades et al, 2010).  Thus, the PNPase-coupled assay provides a facile method to determine the 
activity of the overall ACCase system with a single measurement. 
 
 
Kinetic Model of the Inhibition of Carboxyltransferase Activity by mRNA 
The first task in constructing a mathematical model of the interactions within the CT 
system is to represent the inhibition of CT activity by mRNA. The chemical reactions that 
portray the mutually exclusive binding of substrate or mRNA exhibited by the enzyme are the 
following:   
                                            (1)  
where ki > 0, i = s, -s, p, m,-m are the microscopic rate coefficients characterizing the velocity of 
the reactions, S denotes the substrate (acetyl-CoA), P denotes the product (malonyl-CoA), and 
mRNA denotes the combined mRNAα and mRNAβ.  Note that this combination eliminates 
redundancy in the model while not affecting its accuracy since the α and β subunit mRNAs 
behave identically with respect to binding to CT. 
Using mass action kinetics (Edelstein-Keshet, 2005; Érdi & Tóth, 1989), the dynamics 
for the system of chemical reactions in (1) is given by 
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                                      (2) 
where x1 = [CT-S], x2 = [P], x3 = [CT-mRNA], x4 = [S], x5 = [CT], x6 = [mRNA], [·] represents 
the substance concentration, and u is the input accounting for the addition of acetyl-CoA to the 
system.  The system (2) with u = 0 has the vector form  where . 
The ordering of the state variables in (2) was motivated by convenience of obtaining an 
appropriate reduced-order version of (2) to facilitate its analysis (Chellaboina et al, 2009).  That 
is, the model (2) with u = 0 satisfies the following constraint equations for all time 
                                    (3) 
where t0 is the initial time, c1 is a non-negative constant, and c2 and c3 are positive constants.  
The first equation in (3) expresses the concept that substrate and product can only be converted 
to one another and their sum is always constant.  The latter two equations in (3) represent this 
conservation of matter applied to CT and mRNA, respectively, as these substances are neither 
created nor destroyed in this system, but only allowed to bind other molecules.  Applying (3) to 
(2) with u = 0 yields the following reduced-order system 
:	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                                 (4) 
The reduced-order model in (4) will be used next to analyze the stability of the equilibrium 
points of (2). 
Equilibrium Point Analysis 
The equilibrium points of a kinetic differential equation and their stability properties are 
generally related to the presence/absence of homeostasis in the corresponding biological system 
(Edelstein-Keshet, 2005).  In the specific case of the CT system, the equilibrium point analysis 
can elucidate the dynamic properties of the log and stationary phases shown in Figure 3.1. 
The equilibrium points of (4) are obtained by setting φr(z) = 0 and solving for z, i.e., 
equating the right-hand side of each equation in (4) to zero and solving them simultaneously.  To 
this end, the second equation in (4) gives x1 = 0.  Using this result in the first equation in (4) 
gives two possible solutions: x2 = c1 or x3 = c2.  The latter solution, when applied to the third 
equation in (4), leads to x3 = 0, which is a contradiction since from (3) we know that c2 > 0 (the 
system must always have a non-zero amount of free and bound CT).  Therefore, the only valid 
solution to the first equation is x2 = c1.  Thus, the system (4) has a unique, non-trivial equilibrium 
point of the form 
                                                               (5) 
where  
                          (6) 
It follows from (3) and (5) that the corresponding, unique equilibrium point for (2) is then 
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                                              (7) 
Obviously, (7) can also be arrived at by setting f(x) = 0 and solving for x.  In other words, similar 
to what was done with (4), the right side of each of the six equations in (2) could be set to zero 
and solved simultaneously, arriving at the same values for xi in (7). 
Next, to analyze the local stability of (5), we first linearize (4) about (5) to obtain the 
linearized system matrix (Edelstein-Keshet, 2005) 
                                            (8) 
where 
      (9) 
The eigenvalues (λ) of (8) are determined from 
               (10) 
where I is the 3×3 identity matrix.  Since ηi < 0, i = 1, 2, 3, all the eigenvalues of (8) have 
negative real parts, and (5) is therefore a locally asymptotically stable (LAS) equilibrium of the 
reduced-order system (4).  Under the assumption that stability is preserved by the model 
reduction, (7) is hence LAS for the original system (2). 
Simulation Results 
The model (2) was simulated with the rate coefficients in (2) set to 
               (11) 
where it was assumed that the associations of CT with S and mRNA are diffusion limited.  The 
rate coefficients for CT-S and CT-RNA dissociation and the rate coefficient of product formation 
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were calculated from experimentally-determined binding constants and maximal velocity, 
respectively (Table 3.1).  It is first shown how (2) can achieve stable equilibrium concentrations 
prior to and following perturbation of the system by the addition of acetyl-CoA.  Specifically, the 
simulation begins with the system in the stationary phase due to the presence of initial 
concentrations of only free CT and mRNA, transitions to the log phase due to influx of acetyl-
CoA, and then returns to the stationary phase after near-depletion of acetyl-CoA.  To this end, 
the initial conditions of (2) are set to  
                              (12) 
and the acetyl-CoA supply rate to 
                                                    (13) 
In (13), t = 0.1 s marks the beginning of the addition of acetyl-CoA to the system and the 
transition to the log phase.  At t = 10 s, the supply of acetyl-CoA is turned off, marking the 
beginning of the slow transition back to the stationary phase, during which acetyl-CoA is being 
converted to product. 
The results of the simulation are shown in Figure 3.2, where the time variable is plotted in 
minutes on a logarithmic scale for ease of visualization of the results.  The vertical, dashed lines 
in Figure 3.2 mark either the end of the first stationary phase defined by the appearance of 
acetyl-CoA at 0.1 s, or the approximate end of the transition back to the stationary phase after 
near-depletion of acetyl-CoA.  From the profiles of [CT], [mRNA], and [CT-mRNA], we can see 
that it takes no more than 10-3 min (60 ms) for the system to reach the steady state of first 
stationary phase, where CT and mRNA bind one another in an attempt to achieve equilibrium 
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with respect to the second reaction in (1).  During addition of acetyl-CoA (0.1 to 10 s), [CT-
mRNA] falls in response to free CT binding acetyl-CoA ([CT-S] increases), shifting the 
equilibrium of the second reaction in (1) toward the left via removal of CT.  There is also a 
concomitant rise in [mRNA].  Once the substrate supply is turned off, the system takes 
approximately 70 min to revert to the steady state condition of the stationary phase.  That is, 
notice from Figure 3.2 that all concentrations at t = 102 min have the same values as at t = 10-3 
min, with the obvious exception of [P]. 
It is insightful to interpret these simulation results in light of the equilibrium point 
analysis of the previous section.  Based on (11) and (12), the equilibrium point (7) is given by 
                            (14) 
where c1 was defined in (3) and depends on the initial time.  Observe in Figure 3.2 that (14) with 
c1 = 0 corresponds to the steady state of the first stationary phase.  Furthermore, (14) with c1 = 
x1(10 s) + x2(10 s) + x4(10 s) = 9.909×10-4  M corresponds to the steady state of the second 
stationary phase.1  Notice that the addition of substrate perturbs the system away from its 
equilibrium point.  However, the system does eventually return to the equilibrium state once the 
substrate supply is nearly exhausted.  Thus, the stationary phase is a stable equilibrium of the in 
vitro CT system. 
The results presented so far show that the model (2) qualitatively captures the negative 
feedback interaction between CT and mRNA proposed in Meades, et al (2010), which was 
illustrated in Figure 3.1.  To verify that the model also agrees quantitatively with the actual in 
vitro system, the initial velocity v predicted by the model was compared with the experimental 
                                                 
1 At t = 10 s the substrate supply is turned off (see (13)), marking the “initial time” for the slow transition back to the 
first equilibrium state. 
82 
 
values listed in Table 3.1.  The model initial velocity was determined by plotting  (≈ v) versus 
x4 (= [S]) after simulating (2) for the initial conditions 
             (15) 
 
Table 3.1 
Experimental initial velocities (min-1) for increasing amounts of mRNA at varying acetyl-
CoA concentrations. 
Total [mRNA]a 
(nM) 0 10 48 199.2 
[acetyl-CoA] (µM)     
600 227.7 223.9 215.4 199.6 
300 208.8 204.8 189.8 179.4 
150 168.6 163.0 151.8 138.0 
75 149.2 142.0 126.8 102.6 
40 117.4 108.7 88.18 58.84 
20 96.09 88.58 54.58 25.98 
10 78.13 59.54 29.50 12.84  
a Total [mRNA] = [mRNAα] + [mRNAβ]. 
The ATP and BCCP concentrations were held constant at 200 and 1.12 µM, respectively. 
 
The comparison between the model and the experimental data is shown in Figure 3.3.  
The results indicate a very good agreement between the two.  From the inset of Figure 3.3, where 
the initial velocity curve for the system with x6(0) = 0 is re-plotted to show higher values of 
substrate concentration, it is clear that the mathematical model also predicts the same Vmax of 230 
min-1 as the experimental data (see Experimental System section).  When the same type of 
analysis is done at each concentration of mRNA inhibitor the same Vmax is calculated, indicating 
competitive inhibition (data not shown).  The high degree of concurrence between experimental  
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Figure 3.2.  Simulation showing transition between phases for CT system without translation: 
states x1-8(t) and input u(t). 
 
and simulation data suggests that the proposed dynamic model accurately depicts the mRNA 
inhibition of enzymatic activity of CT.  However, this simulation of mRNA inhibition of CT 
84 
 
catalytic function incorporates neither translation of new CT from mRNA nor the ability of CT 
to attenuate translation from the mRNA template.  Since these are integral components of the 
negative feedback regulation they need to be included in the model. 
 
 
Figure 3.3.  Comparison of initial velocities for different concentrations of mRNA (0, 10, 48, and 
199.2 nM). 
 
Feedback Regulation of Translation by Carboxyltransferase 
Here, the mathematical model in (2) is expanded to include translation of new CT from 
mRNA and repression of this translation by CT.  The chemical reactions that describe these 
interactions are the following: 
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                                   (16) 
where km, k-m, ks, k-s, and kp are as in (1) and kt is the translation rate coefficient. The dynamic 
model for (16) is given by 
                             (17)  
where the state variables and u are defined as in (2). 
Results 
An experiment was conducted to test if the above model of CT translation can account 
for actual experimental data.  Accurately measuring the small amount of CT produced in an in 
vitro translation experiment is not possible in the presence of increasing initial amounts of 
enzymatically active CT.  Therefore, in order to detect (using the PNPase-coupled assay) the 
small amount of de novo CT produced by in vitro translation in the presence of a large amount of 
exogenously added CT, a catalytically inactive mutant of CT was used for the exogenously 
added CT.  Mutation of glycine 206 to valine in the α subunit of CT (αG206V) results in an 
enzyme that has no catalytic activity, but retains the ability to bind mRNA with an affinity (Kd = 
205±26 nM) that is well within the range of affinities observed by Meades, et al (2010).  Equally 
important, the substrate acetyl-CoA can also compete with mRNA for binding to the αG206V 
variant (data not shown).  This is because acetyl-CoA binds to the β subunit while the mutation 
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rendering the enzyme inactive is in the α subunit.  Thus, the αG206V variant CT serves as an 
appropriate mimic for wild-type CT in terms of binding acetyl-CoA and attenuating translation 
by binding mRNA, but  remains catalytically silent when measuring the level of de novo CT 
using the PNPase-coupled assay.  It is important to note that the inhibitory effect of mRNA is 
absent in these detection assays because the in vitro translation reactions were treated with 
RNase prior to analysis in order to accurately determine the total amount of CT expressed. 
The effect of increasing, initial amounts of the αG206V variant on mRNA translation in 
the absence of acetyl-CoA is shown in the first and second columns of Table 3.2.  The 
experiment was conducted with no acetyl-CoA because the E. coli extract used for experimental 
measurements is an undefined mixture of the cytosolic components, many of which may bind or 
associate with acetyl-CoA (Kim & Gadd, 2008), thereby making the effective concentration in 
the reaction unknown.  Note from Table 3.2 that there is a progressive decrease in translation as 
the initial concentration of CT is increased.  This is not surprising since larger concentrations of 
CT promote binding with mRNA, thus inhibiting translation of new CT (see (16)).  When acetyl-
CoA was added to the translation mixture the results did not fit the simulation model.  The 
discrepancy may result from the fact that the E. coli extract used for experimental measurements 
is an undefined mixture of the cytosolic components, many of which may bind or associate with 
acetyl-CoA (Kim & Gadd, 2008), thereby makinge the effective concentration in the reaction 
unknown. 
In simulating (17) for comparison with the experimental data in Table 3.2, the following 
rate coefficients and initial conditions were used 
          (18)  
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                               (19) 
Note that the product conversion coefficient was set to zero to more closely mimic the conditions 
in the experimental setup, where conversion to product did not occur due to absence of the 
second substrate in this bi-substrate reaction.  The value of the translation coefficient kt was 
chosen so that the concentration of translated-only CT at t = 60 min in the simulation matched as 
closely as possible the experimental value for the case where the initial concentration of CT was 
zero; see first row of Table 3.2.  When [S](0) = [CT](0) = 0 the system is initially composed of 
only the third reaction in (16), establishing a baseline value in the absence of the αG206V variant 
of CT.  That is, the experimental and calculated values are fixed at a common origin, which then 
allows for a direct comparison between the two as increasing amounts of the αG206V variant of 
CT are added to the system. 
Table 3.2 
Experimental and simulation data after 60 minutes of in vitro translation with no acetyl-
CoA. 
Initial 
[αG206V CT] 
(µM) 
Translated 
[CT]a,b (µM)  
Simulated 
Translated [CT] 
(µM) 
0 4.74 4.737 
0.1 4.64 4.643 
1 3.74 3.841 
4 0.750 2.191 
a Translated [CT] measured as active enzyme in the PNPase-coupled CT assay. 
b Errors in [CT] measurements less than 0.005 µM. 
The ATP and BCCP concentrations in the detection assay were held constant at 80 and 1.12 µM, 
respectively. 
 
The simulation results for the amount of translated CT at t = 60 min are shown in the 
third column of Table 3.2 and in Figure 3.4.  The first aspect to be noted is that the simulation 
data agrees with the trend observed from the experiments that larger initial concentrations of CT 
lead to smaller concentrations of translated CT.  Second, as seen from Figure 3.4, the model 
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quantitatively agrees with the experiment at low initial concentrations of CT, but predicts higher 
concentrations of translated [CT] than the experiment as the initial amount of CT is increased.  
The difference between the experimental and calculated values may be attributed to the fact that 
CT binds non-specifically to tRNA and rRNA (Meades et al, 2010), both of which are required 
for translation.  At higher levels of the αG206V variant of CT, the enzyme not only binds to 
mRNA but also binds to tRNA and possibly exposed rRNA, which would enhance the inhibitory 
effect on translation more than predicted by the model. 
 
Figure 3.4.  Comparison of amount of translated-only CT after 1 hour for different initial 
concentrations of CT. 
Recall that the results shown in Figure 3.2 were obtained without the presence of 
translation.  Thus, the model in (17) is evaluated next with respect to its ability to reproduce the 
negative feedback mechanism depicted by Figure 3.1.  To this end, the initial conditions and 
substrate supply rate shown in (12) and (13) were applied to (17) with kp set to the value in (11) 
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and the other rate coefficients as in (18).  The results are shown in Figure 3.5, where the time 
axis and the vertical axis of [CT] are plotted in log scale for the ease of visualization (all other 
vertical axes have a linear scale).  Before 0.1 s (= 1.3×10-3 min), when there is no substrate, the 
system is in the stationary phase, where CT binds to mRNA (inhibiting translation) and causing 
free [mRNA] and [CT] to decrease.  After the supply of substrate is turned on, the system goes 
into the log phase and substrate begins to compete with mRNA to bind CT.  Thus, [mRNA] 
increases and [CT-mRNA] decreases.  During this period, [CT] continues decreasing as it is 
binding substrate, but at a lower rate than in Figure 3.2 since translation of new CT is occurring.  
When the supply of substrate is turned off, the first equation in (16) comes to equilibrium with 
respect to CT binding substrate and [S] begins decreasing as it is converted to product.  
Concurrently, unbound mRNA yields translation of new CT.  It takes about 1 min for the 
substrate to be depleted, after which the translation rate slows down because the binding of CT to 
mRNA inhibits the translation process.  The system eventually returns to the stationary phase 
where [mRNA] and the rate of translation are kept at a basal level. 
Conclusions 
This paper illustrates how the application of rigorous quantitative analysis can help to 
reconcile the separate observations reported by Meades et al. (2010) for the CT system into a 
unifying dynamic negative feedback mechanism.  The results show that there is a good 
correlation between the experimental observations and the mathematical model predictions for 
the CT system describing inhibition of CT enzymatic activity by subunit mRNA.  Additionally, 
the mathematical model incorporates the translational inhibition by CT upon binding to subunit 
mRNA, which was observed experimentally.  This agreement between experiment and theory 
validates the proposed in silico negative feedback model for the CT system. 
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Figure 3.5. Simulation showing transition between phases for CT system with translation: states 
x1-8(t) and input u(t). 
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CHAPTER 4 
CONCLUSIONS 
Summary 
Results from the experiments presented herein advance the knowledge of how the 
bacterial enzyme acetyl-CoA carboxylase is able to regulate its own activity and control 
expression of its carboxyltransferase subunits, exemplified by the Escherichia coli model 
system.  Specifically, they demonstrate that the mutually exclusive interactions of the 
carboxyltransferase (CT) component with either its substrate acetyl-CoA or subunit mRNA are 
not independent occurrences but part of a coordinated negative feedback control mechanism. 
The first study aimed to determine the role played by the 4-cysteine zinc-binding domain 
on the β-subunit of CT.  Through site-directed mutagenesis of the coordinating ligands, the zinc 
finger was shown to play a vital role not only in the catalytic activity of the enzyme but also in 
its nucleic-acid binding function.  Furthermore, these two dueling functions are structurally and 
functionally linked through the zinc-binding domain, suggesting a reason for the conservation of 
this motif in the prokaryotic version of CT, which is notably absent from the eukaryotic enzyme.  
Data show preferential binding of E. coli CT to mRNA coding for its two subunits and the 
capacity of acetyl-CoA to disrupt this interaction.  Subunit mRNA is able to inhibit the catalytic 
activity of CT, while CT binding to subunit mRNA attenuates translation of the subunits.  Taken 
together, these data lead to a model of negative feedback regulation whereby CT is able to sense 
a drop in the cellular concentration of acetyl-CoA and attenuate its activity and translation 
simultaneously through binding subunit mRNA.  The mechanism also provides for a rapid 
response to an influx of acetyl-CoA, allowing immediate catalysis and translation of new CT as 
substrate displaces enzyme from mRNA. 
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Following the development of the negative feedback model of regulation for CT, it was 
subjected to verification as a dynamic system, i.e. the specific interactions of CT with acetyl-
CoA and mRNA exist as part of a single mechanism for regulating the production of fatty acids 
in response to growth conditions.  A mathematical model was created as a series of non-linear 
differential equations from the rates of changes of system components, governed by 
experimentally determined dissociation constants and physical constraints of conservation of 
matter.  The model and accompanying simulations agree with experimental data pertaining to 
mRNA inhibition of CT and negative feedback regulation of translation. 
Evolutionary Coupling of Functions 
A self-regulating system for the activity and expression of CT in E. coli and the 
possibility of similar mechanisms in other bacteria also harboring a zinc-binding domain in CT 
suggests an evolutionary conserved coupling of enzymatic activity to the mRNA binding 
capacity.  By linking the two functions through a common structural characteristic essential to 
both roles, selective pressure to retain the zinc finger for catalysis also serves as a means to 
preserve the regulatory function.  Further evidence for retention of the zinc finger as an 
indispensable element to the catalyic function of the enzyme resides in the chloroplasts of plants.  
Many proteins once encoded by the genetic material of the chloroplast have had their genes 
relocated to the nuclear chromosome.  Of the four acetyl-CoA carboxylase gene products (accA-
D) found in chloroplasts, only accD, the β-subunit of CT, remains encoded by the chloroplast for 
most plants.  Like many bacteria, this protein has a zinc finger motif essential for catalysis.  
Perhaps the lack of relocation of this subunit in chloroplasts signifies a continued use by nearly 
all plants of the prokaryotic regulatory function described here for E. coli. 
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Future Experiments 
It is now clear that CT from E. coli preferentially binds its own subunit mRNA over other 
nucleic acids.  What structural characteristics of these two mRNAs does the protein recognize?  
To address the question, two experiments are proposed, selective 2´-hydroxyl acylation analyzed 
by primer extension (SHAPE), and systematic evolution of ligands by exponential enrichment 
(SELEX).  The former method takes advantage of the fact that RNA adopts significant secondary 
and tertiary structure in solution as well as in contact with other molecules such as proteins.  
Covalent modification at the 2´-hydroxyl position of RNA at conformationally flexible 
nucleotides forms a 2´-O-adduct.  These adducts then hinder the progress of subsequent 
polymerization of DNA from the modified RNA template by reverse transcriptase, identifying 
regions of the original RNA relatively free of higher order structure.  SHAPE probing of the 
structure of CT subunit mRNA in the absence and presence of CT may shed some light on more 
specific regions of the mRNA involved in binding as well as information on structural changes to 
the mRNA upon binding.  A SELEX experiment incorporates an iterative selection process for 
more strongly binding random RNA sequences to a target molecule (in this case, CT), followed 
by comparison to the known sequence of the CT subunit mRNAs to identify regions in close 
association with the protein.  Together, these two techinques could help discern the mechanism 
of recognition for CT binding to its own mRNA. 
The chemical mechanism of CT has a yet to be identified catalytic base that abstracts a 
proton from acetyl-CoA.  What residues could serve in this role?  The matter will be addressed 
through structure-assisted, site-directed mutation of residues potentially involved in the 
chemistry.  A single deprotonated group on the enzyme with a pK < 7.6 is required for activity.  
This, along with the ability of N-ethylmaleimide to deactivate the enzyme, first suggested a 
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cysteine residue as the general base.  In light of structural evidence indicating a lack of cysteines 
in the immediate vicinity of the active site, attention has turned to other potential residues.  If 
allowed to move closer to the active site through a conformation change in the N-terminal zinc 
domain upon acetyl-CoA binding, H51 could potentially act as the catalytic base.  Cysteine 30, 
one of the coordinating residues in the zinc finger, appears to play a prominent role, as its 
absence results in a significant drop in enzymatic activity.  Consistent with previous data is a 
mechanism whereby closure of the zinc domain upon acetyl-CoA binding promotes 
rearrangement of zinc coordination with exchange of C30 for H52 or a water molecule.  This 
shuffling of zinc coordination would free C30 to act in concert with the now properly positioned 
H51 for proton abstraction from acetyl-CoA.  Analysis of the effects of mutations of these 
suspect residues on activity as well as structural information for these variants in complex with 
acetyl-CoA could lead to elucidation of the catalytic base. 
 
96 
 
APPENDIX: PERMISSION TO INCLUDE PUBLISHED WORK 
 
Dear Glen Meades,   
RE: NARESE- Nucleic Acids Research, March 1, 2010; 38(4):1217-1227. A tale of two functions: 
enzymatic activity and translational repression by carboxyltransferase. 
Thank you for your email dated 10 June 2010 requesting permission to reprint the above material.  Our 
permission is granted without fee to reproduce the material.  
Use of the above is restricted to reproduction of article in doctoral dissertation to Louisiana State 
University available in print/electronic format only, to be used only in the English language. This 
permission is limited to this particular use and does not allow you to use it elsewhere or in any other 
format other than specified above. 
Please include a credit line in your publication citing full details of the Oxford University Press publication 
which is the source of the material and by permission of Oxford University Press or the sponsoring 
society if this is a society journal. 
If the credit line or acknowledgement in our publication indicates that material including any 
illustrations/figures etc was drawn or modified from an earlier source it will be necessary for you to also 
clear permission with the original publisher.  If this permission has not been obtained, please note that 
this material cannot be included in your publication/photocopies. 
Please do not hesitate to contact me if I can be of any further assistance.  
Yours sincerely,  
Mubashar Khattak  
Permissions Assistant  
Oxford University Press  
Great Clarendon Street  
Oxford  
OX2 6DP  
Email: mubashar.khattak@oup.com 
97 
 
VITA 
 
Glen Meades, Jr., is the eldest son of Glen Meades, Sr., and Linda K. Salassi.  He was 
born in New Orleans, Louisiana, in January, 1977.  Having received tremendous encouragement 
from family, teachers, and friends to pursue his educational goals, he will be the first in his 
immediate family to receive a doctoral degree.  His future plans include moving to Atlanta, 
Georgia, to continue research in RNA crystallography as a postdoctoral researcher in the 
laboratory of Dr. Christine Dunham at Emory University. 
